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Chapter 1 
HISTORICAL INTRODUCTION 
As early as 1909 hypotensive substances were found to be present 
in human urine. Indeed substances from human urine with hypotensive 
activity have been reported several times {ErdOs, 1966), though ex-
tensive work to characterize the biochemical agents was not carried 
out until 1926 (Frey et al., 1950). The hypotensive activity was 
ascribed to a substance they termed kallikrein; the word derived from 
the Greek kallikreas for pancreas, since this organ was found to 
possess large amounts of the hypotensive activity. In 1937 it was 
demonstrated that a mixture of human plasma and an extract of salivary 
gland caused contraction of the isolated guinea-pig ileum (Werle, 
1937). This substance was initially called Darmkontrahierende Sub-
stanz (Dk). It was further demonstrated to be a polypeptide originating 
from enzymatic cleavage of an a-globulin in plasma by kallikrein 
(Frey et al., 1950). The a-globulin was called kallidinogen and the 
polypeptide, kallidin. 
In 1949 Rocha e Silva and his co-workers also described a hypoten-
sive polypeptide in their studies on the effect of the venom of the 
snake Bothrops jararaca and trypsin on dog blood. They reported that 
incubation of the venom or trypsin with the pseudoglobulin fraction 
of plasma resulted in the formation of a potent vasodilator and smooth 
muscle stimulating substance. The experiments further indicated that 
these pharmacological actions were due to a substance whose destruction 
by enzymes in plasma or by a chemical means was consistent with the 
hypothesis that it was a polypeptide. When compared to histamine or 
acetylcholine the substance contracted the guinea-pig ileum slowly, 
and neither atropine nor anti-histamine agents antagonized its action. 
The polypeptide was called bradykinin to describe the slow contracting 
action. During purification of bradykinin both the hypotensive and 
spasmogenic actions remained inseparable (Rocha e Silva, 1960), indi-
cating the presence of a single substance. At the time it was not 
possible to decide if bradykinin was similar to other substances formed 
from plasma, now known as plasma kinins. 
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In the following years the amino-acid composition and synthesis 
was worked out (Elliot et al., 1960b; Boissonnas et al., 1960). 
Initially it was indicated that bradykinin was an octapeptide (Elliot 
et al., 1960b), however synthesis of several octapeptides with the 
required structure only gave inactive peptides (Boissonnas et a!., 
1960). One of the synthetic peptides had nine amino-acids and had an 
activity similar to bradykinin (Elliot et al., 1960c). Re-examination 
of the original experimental data (Elliot et al., 1960c) showed that 
indeed bradykinin was a nonapeptide. 
It was suggested from time to time that because of the similar 
properties of bradykinin and kallidin, that actually they were the 
same peptide. The relationship between kallidin and bradykinin was 
finally resolved when it was shown that human urinary kallikrein 
releases two polypeptides from human plasma (Pierce and Webster, 
1961), one of these being a decapeptide, which they called kallidin-10, 
and the other a nonapeptide, kallidin-9. Kallidin-9 was found to be 
identical to bradykinin, while kallidin-10 had an extra lysine residue 
at the N-terminal carbon atom. At the same time Werle et al. (1961) 
independently came to the same conclusion. 
Numerous additional kinins have now been found, the generic term 
'kinin' being coined to apply to those polypeptides with properties 
similar to bradykinin and kallidin (Schachter, 1968). Some of these 
kinins include methionyl-lysyl-bradykinin, colostrokinin, neurokinin, 
wasp venom kinin and the kinins released by npermeabili ty globulin 11 , 
The structures of some kinins are shown in fig. 1. Not all the kinins 
have been fully characterized, but it is probable they will closely 
resemble bradykinin and kallidin. 
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N-terminol C-terminal----.. 
Bradykinin (kallidin-], kallidin-9, 
kinin-9, nonapeptide) 
Arg- Pro- Pro-G I y- Phe-Ser- Pro- Phe-Arg 
Lysyl-brodykinin (kallidin, kallidin-11, 
kallidin- 10, kinin- 10, decapeptide) 
Methionyl-lysyl-bradykinin (methionyl-
kallidin, kinin-11, undecapeptide) 
L ys-Arg- Pro- Pro-G I y- Phe-Ser- Pro- Phe-Arg 
Met-L yJhg- Pco- Pco- G I y- Phe-S ec- Pco- Phe-Acg 
Phyllokinin Arg- Pro- Pro-G I y- Phe-Ser-Pro-Phe-Arg 
lieu 
T}-r 
HS03 
Eledoisin Met-Leu-GI y- I I eu- Phe-Al a-Asp- L ys-Ser- Pro- Pyr 
Physal aemi n Met-Leu-Giy-Tyr-Phe-Lys-Asp- Pro -Asp-AI o -Pyr 
' (NH
2
) 
Caerulein Phe-Asp-Met-T rp-GI y-Thr-T yr-Asp-GI u-Pyr 
' HS03 
Fig. 1. Schematic repesentation of the chemical composition of some 
kinins and kinin-like peptides. The names in parentheses are 
synonyms. The basic kinin structure is indicated by the box. 
THE KININ SYSTEM 
In connection with the kinins two further factors should be con-
sidered, namely the production and destruction. On consideration of 
the production of kinins there are a number of substances that have 
assumed an important role, these being the "permeability factor/dil 11 
(PF/dil) and the Hageman factor. PF/dil is a plasma protein that 
induces increased vascular permeability at the site of intra dermaL 
injection, and was originally described as a factor present in the 
diluted serum of guinea-pigs (Mackay et al., 1953). The action of 
PF/dil was not blocked by anti-histamines, but was blocked by agents 
that block kallikrein. At the time it was not clear whether the two 
agents were really different, though it was later shown that PF/dil 
and Hageman factor could be separated chromatographically (Becker 
and Kagen, 1964). It is now considered that PF/dil activates kalli-
11 
krein, which in turn results in the release of kinins (Mason and 
Miles~ 1962). 
Hageman factor was originally described as a clotting factor 
congenitally missing from the plasma of Mr. John Hageman (Ratnoff, 
1966). The Hageman factor is a plasma protein, that after activation 
by glass or other particulate surfaces can initiate a series of 
reactions, called the Intrinsic clotting mechanism. PF/dil does not 
form in blood protected from contact with glass. It was suggested 
that Hageman factor might be an essential step in the activation of 
PF/dil (Margolis, 1959). It has been postulated that human plasma 
contains two kinin-forming systems (Vogt, 1966; Vogt et al., 1967) 
~ig. 2a), in which kininogenase II is activated directly by Hageman 
factor, but kininogenase I (kallikreinogen) indirectly via PF/dil. 
They also concluded that kininogenase II activates kininogenase I. 
Kininogenase I has been equated to serum kallikrein (Vogt, 1966). 
Kininogenase I is identical, functionally, with the bovine kininogen 
preparation of Habermann et al. (1963). 
The type of kinin produced is dependent on the nature of the 
substrate and the kallikrein. It is known that pig serum kallikrein 
produces bradykinin from bovine kininogen, whereas pancreatic kalli-
krein produces kallidin (Habermann, 1966). Hhen meth-lys-bradykinin 
is the substrate serum kallikrein forms bradykinin, but the pancreatic 
kallikrein is inactive. These results indicated that plasma kallikrein 
is not formed in the pancreas. Kallidin, formed by the action of 
kallikrein, can be converted into bradykinin by an aminopeptidase 
present in blood plasma (Webster and Pierce, 1963; ErdOs et al., 1963~ 
Trypsin has also been found to be active in converting kallidin to 
bradykinin (Webster and Pierce, 1963) and furthermore has been shown 
to liberate a bradykinin-like substance from kininogen, possibly both 
directly and indirectly by activating plasma kallikrein (Herle, 1963; 
Ferreira and Rocha e Silva, 1969). 
Kinins are rapidly destroyed in plasma and most other body fluids, 
the enzymes that destroy the kinins being collectively known as 
kini:qases. In human plasm'a the enzyme is called carboxypeptidase-N, 
and has been shown to break the Phe-Arg bond in bradykinin or kallidin 
(ErdOs and Sloane, 1962). Recently it has been shown that the lung 
kininases are more important for the removal of circulating kinins 
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than the plasma kininases (Ferreira and Vane, 1967; Alabaster and 
Bakhle, 1972). The kininases in plasma have been shown to have an 
enhanced activity in the presence of adrenaline (Mashford and Zacest, 
1967), suggesting a possible control mechanism. 
Further discussion of the kininases will be given in a later section. 
These observations have lead to the proposal of the reaction 
sequence (fig. 2a,b) in human plasma resulting in the formation 
(Miles, 1964; Becker and Kagen, 1964) and destruction (ErdOs, 1966) 
of kinins. Complete biochemical proof is still unavailable, but the 
existing evidence supports such a pathway. 
Prekininogenase I 
(koll ikreinogen) 
PF/d;l~ 
Kininogenase I 
K;n;nogen l(koll;kce\ 
• Kinin 
Preki ninogenose II 
l ----- Hogemon .------ Factor /'"""'~";"•"" " 
Fig. 2a. Schema~ic representation of the two kinin-forming systems 
present in human p~asma (Vogt~ 1966). Kininogenase I is the 
enzyme absent from glass treated plasma; kininogenase II is 
the enzyme present in active form after glass contact. 
Kininogen I is the substrate ~argely ~eft intact; kininogen 
II is the sWJstrate consumed dur>ing glass activation of plasma. 
Cbgem~~ 
Foc'o' 
Ti,vo~l P,oPFd<l 
"""""" ,,:.,", - I ,,,,,,,,,,,, ;;;,::"' :',,, --~C''"'"'",. 
Kolii,,oin 
<(ini•1ogeno1o \1 
'GI~noola,: ~ PI><O>O' 
Kollid,n-----=---- K,~,noge~ il,ocyUcin 
"''"""-.. !~. ~!----"''''' plo1na Oil'I~O 
lnoct1v0 poptode> P"Ptidas(! Inactive peptOde> 
Fig. 2b. Schematic representation of one of the biochemical pathways 
for the formation and destruction of kinins. In some cases 
ka~likrein produces kallidin (see text)~ which can be con-
verted into bradykinin by an aminopeptidase. 
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THE ACTIONS OF KININS 
Kinins have been implicated in several physiological processes, 
including regulation of blood flow in the salivary gland (Hilton and 
Lewis, 1956), constriction of the ductus arteriosus and conversion 
of the foetal blood circulation to that of an adult (Melman et al., 
1968). They have also been shown to be capable of contracting smooth 
muscle (Rocha e Silva et al., 1949), inducing hypotension (Rocha e 
Silva et al., 1949), increasing blood flow (Hilton and Lewis, 1956) 
and microvascular permeability (Holdstock et al., 1957), inciting pain 
(Armstrong et al., 1957) and possibly causing the migration of 
granulocytic leukocytes (Graham et al., 1965; Spector and Willoughby, 
1964). 
It has been proposed that kinins have a primary etiological role 
in the development of the acute inflammatory response, and as such 
are thought to be implicated in the pathogenesis of various forms 
of acute arthritis (Melman et al., 1967; Kellermeyer, 1967), asthma 
(Herxheimer and Stresemann, 1961; Abe et al., 1967), foreign body 
granuloma and pneumoconiosis (Warren and Kellermeyer, 1968), endo-
toxin shock (Nies et al., 1968), the Schwartzman reaction (Halpern, 
1964), heriditary angioneurotic oedema (Donaldson, 1968), migraine 
headaches (Ostfeld et al., 1957) and acute inflammation associated 
with thermal burns (Rocha e Silva and Rosenthal, 1961). 
The following sections of the introduction will be devoted to 
giving the reader an insight into the evidence for proposing kinins 
as mediators of some acute inflammatory reactions, and also some 
current ideas concerning the mechanisms. In these sections will be 
discussed the involvement of catecholamines and prostaglandins. 
These ideas will be extended to the actions of bradykinin on vascular 
and non-vascular smooth muscle, together with the known antagonists 
and potentiators of bradykinin. In the final section of the intro-
duction will be presented some of the initial ideas and observations 
that have directed the work of this thesis. 
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INFLAMMATION 
The reaction of a tissue to sub-lethal injury is known as in-
flammation. In its acute form it is characterized by vasodilatation, 
increased vascular permeability and oedema, pain and the migration 
and extravascular accumulation of leukocytes. With severe injury 
these events occur almost simultaneously, however with milder stimulus 
there is a characteristic order of responses. The increase in the 
vascular permeability to a mild stimulus tends to be biphasic, with 
an earlier, transient phase and a delayed, sustained phase (Spector, 
1964; Wilhelm and Mason, 1960). 
In models of mild inflammation the vascular permeability present 
in the early transient phase has been shown by the colloidal labelling 
techniques to involve only the small venules (Wells and Miles, 1963), 
while during the delayed phase the capillaries also become heavily 
labelled (Wells and Miles, 1963; Cotran and Majno, 1964; Spector et 
al., 1965) depending on the intensity and nature of the stimulus. 
The results with capillaries do not necessarily indicate that there 
is a great exudation of fluid or protein, since electron microscopy 
has revealed that carbon can be trapped in fibrin plugs within the 
vessel (Cotran, 1965). 
KININS AS MEDIATORS OF INFLAMMATORY RESPONSES 
Do the actions of kinins resemble the features of inflammation 
As described earlier bradykinin can cause vasodilatation, in-
creased vascular permeability and oedema, and pain (Elliot et al., 
1960a; Konzett and StUrmer, 1950; Lewis, 1970). Kinins appear to be 
relatively ineffective at promoting migration of leukocytes (Spector 
and Willoughby, 1964). At high concentrations Lewis (1962) observed 
migration and also sticking of leukocytes to the venules of the 
oesentary, but this was not confirmed by Zweifach (1966). Neverthe-
less sticking has been observed for the rabbit ear chamber (Graham 
et al., 1965). Convincing evidence as to the precise role of kinins 
in migration and sticking of leukocytes is unavailable. 
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Are kinins released at the site of injury 
The research investigator is presented with a large array of 
difficulties in the study of kinins~ since they are so rapidly 
destroyed in the body by kininases (Allwood and Lewis~ 1964; Ferreira 
and Vane, 1967) ~ and thus are extremely difficult to measure accurate-
ly in inflammatory exudates. Nevertheless there are a number of 
reports of kinins being found with other mediators at the site of 
local injury. One of these experimental injuries is moderate to 
severe treatment by heat. Histamine and a bradykinin-like substance 
can be shown to be released after scalding the skin of rats and 
collecting the fluid in an air pouch submitted to a temperature of 
96°C for 15 sec (Rocha e Silva and Rosenthal,l961). Under less 
drastic conditions, 54°C, histamine is still released together with 
the production of a bradykinin-like material (Wilhelm and Mason, 1960); 
though under milder conditions, 43-46°C, histamine is no longer re-
leased (Rocha e Silva and Antonio, 1960; Starr and West, 1967). At 
the latter temperature it is known that mast cells are stabilized 
(Mongar and Schild, 1957). Correlation was found to exist between 
the anti-bradykinin activity of some substances in vitro and the 
oedema reducing properties (Garcia Leme and Rocha e Silva, 1965). 
It can also be shown that substances interfering with the release 
of bradykinin from its active precursor in plasma, such as hexa-
dimethrine, inhibited the development of the heat oedema (Garcia 
Leme et al., 1967, 1970) and the yeast oedema (Kellett, 1965). 
Sulphated polysaccharides, which are known to deplete the labile 
pool of bradykininogen, reduced the heat oedema (Garcia Leme et 
al., 1967). More recently it has been suggested that the subcutaneous 
tissue elicits a process leading to plasma extravasation and that 
subcutaneous tissue is the chief site of release of the bradykinin-
like material (Garcia Leme et al., 1970). 
In addition to the thermic oedema, kinin release has been demon-
strated in the carrageenin oedema (Di Rosa and Sorrentino, 1968) and 
the kaolin oedema (Bonta and de Vos, 1966, 1967). Further evidence 
for kinin involvement came from experiments of Edery and Lewis (1963), 
who although could not detect an increase in kinin in the lymph 
draining an injured hind leg of the dog, did, however, find an in-
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crease in kinin-forming activity. 
Do conditions at the site of injury favour kinins 
The formation and accumulation of plasma kinins may be dependent 
on the conditions existing in inflammed tissues. It has been conside-
red that proteolytic enzymes are activated in tissue injury (Beloff 
and Peters, 1945; Ungar, 1947), although it is unclear exactly what 
factors are involved. The acidic environment that prevails in tissue 
damage is thought to activate kallikrein from its inactive precursor 
Oierle, 1934). Further was suggested that in conditions where acid 
metabolites are formed, kallikrein is responsible for the vascular 
effects (Frey et al., 1950). It is still not clear whether changes 
of pH in damaged tissue are sufficient to cause activation. 
In addition to bradykinin it has been shown that the kinin, methio-
nyl-lysyl-bradykinin can be formed after acid activation of kinino-
genases in plasma (Edery and Lewis, 1962). The latter peptide had a 
more prolonged effect than bradykinin, which is considered to be 
attributable to its possible greater resistance to destruction by 
kininases, or conversion to kallidin and bradykinin. Kininases them-
selves appear to be strongly dependent on pH (Edery and Lewis, 1962). 
These authors showed that phosphate buffer, pH 6.0, effectively inhibits 
kininase. At this pH it has been thought that kinin formation is 
decreased (Trautschold, 1968), though incompatible evidence exists 
(Edery and Lewis~ 1962; Zachariae et al., 1967). Further work by 
Aarsen and Kemp ( 1962) showed that cysteine hydrochloride solutions 
(often used to potentiate bradykinin's smooth muscle effects- see 
later section) needed to be neutralized to exclude pH effects on the 
kininases. It seems thus possible that an acid environment provides 
not only the suitable conditions for the formation and accumulation 
of kinins, but may even result in the formation of more stable kinins. 
SUGGESTED MECHANISMS OF ACTION OF BRADYKININ 
Of the kinins investigated it appears that bradykinin is the 
most important and the most potent mediator of vascular permeability 
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(Elliot et al., 1960a; Collier, 1961; Frimmer, 1960; StUrmer and 
Cerletti, 1961; Wilhelm, 1962). The possibility has been advanced 
that catecholamines play a fundamental role in the mechanism of action 
of bradykinin (Rocha e Silva, 1964). Two schools of thought have 
predominated, one suggesting that catecholamines have a pro-inflamma-
tory effect, while the other an anti-inflammatory effect. 
The involvement of catecholamines 
Bradykinin has been shown to liberate catecholarnines from the 
adrenal medulla (Lecompte et al., 1961; Feldberg and Lewis, 1964) and 
also to stimulate the sympathetic ganglia (Lewis and Reit, 1965). 
In the latter respects bradykinin resembles non-nicotinic ganglionic 
stimulants (Lewis and Reit, 1966; Trendelenburg, 1966). Further it 
has been shown that adrenergic blockade and adrenalectomy potentiate 
the hypotensive (Rocha e Silva et al., 1960; Lloyd, 1962; Nakano, 1965) 
and bronchoconstrictor actions of bradykinin (James, 1969). There is 
also evidence available indicating that adrenaline is able to activate 
proteases in vivo (Biggs et al., 1947; Macfarlane and Biggs, 1948). 
This could start a process leading to the release of bradykinin or 
related kinins. Bradykinin has been shown to be released from the 
lungs of rabbits on treatment with doses of catecholamines that in-
duce pulmonary oedema (Di Mattei, 1962). Also it has been shown that 
the kaolin-induced oedema of the rat paw, where there is considered 
to be kinin release, can be suppressed by guanethidine and reserpine 
treatment (Bonta and De Vas, 1966), further suggesting a pro-inflamma-
tory effect of catecholamines. 
Contrary to these ideas it has been proposed that catecholamines 
generally have an anti-inflammatory effect. Inhibitors of the enzyme 
monoamine oxidase can suppress acute inflammatory responses (Northover, 
1963) and also inhibitors of the enzymes DOPA-decarboxylase and dopamine-
S-hydroxylase leads to a significant reduction of deranged permeability 
(Spector and Willoughby~ 1960; Willoughby and Spector, 1954). These 
results suggest that the development of the vascular reaction to injury 
depends partly on the inactivation not· only of adrenaline, but also 
of noradrenaline, DOPA and dopamine~ and that undestroyed these com-
pounds might act as local anti-inflammatory agents. Other indirect 
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evidence supporting the latter ideas has been presented by MOller 
(1962), who showed the disappearance of catecholamines from recently 
injured tissue, Raekalli (1963), who demonstrated an increase in 
monoamine oxidase activity in damaged skin, Jacques (1965), who found 
suppression of the anti-inflammatory activity of amidopyrine by a-
methyl-p-tyrosine, and GOzsy and KatO (1966), who found a delayed 
sensitization to histamine by catecholamines. More direct evidence 
was presented by Northover and Subramanian (1962), who showed that 
noradrenaline and phenylephrine (s. c.) reduced the formaldehyde indu-
ced oedema of the mouse paw, and Brown and West (1965), who demon-
strated that adrenaline (i, d. and s, c.) blocked the dextran and egg 
white oedema. More recently catecholamines have been confirmed to 
have an anti-inflammatory action on the carrageenin-induced rat paw 
oedema, though not in bilaterally adrenalectomized animals (Bhalla 
et al., 1970). This suggested a mechanism related to the pituitary-
adrenal system, and not to local vasoconstriction as suggested by 
Willoughby and Spector ( 1964). 
The experiments of Brown and West (1965) showed that not only 
did adrenaline block the dextran and egg white oedema, but also ex-
ogenously administered glucose. Adrenaline was much more potent than 
glucose. A remarkable correlation has been reported between the anti-
oedemous activity of adrenaline and its hyperglycaemic effects (Kellett, 
1965), in particular was shown that glucose inhibited the oedema, while 
insulin antagonized both the adrenaline and glucose reduction of the 
oedema. It would seem that the anti-inflammatory properties of 
adrenaline are mediated solely through its hyperglycaemic effects. 
It is apparent from the evidence presented that where catecholamines 
are released there is a greater likelyhood of an anti-inflammatory than 
a pro-inflammatory effect, and that this effect may be mediated by an 
action on glucose mobilization. Nevertheless it seems unlikely that 
the increase in vascular permeability and the development of the 
inflammatory response to bradykinin is mediated via a release of 
catecholauines. 
The involvement of prostaglandins 
The plasma kinins and the prostaglandins are alike in two important 
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ways. Firstly, both are endogenous substances that can be liberated 
locally in different parts of the body, and can be rapidly destroyed. 
Secondly, both kinins and prostaglandins potently affect smooth 
muscle, blood vessels and nerves. The prostaglandins are structurally 
unrelated to the kinins. The chemical relationships between some of 
the important prostaglandins are shown in fig. 3 
HO', 
' 
--~COOH 
6 
H 'OH 
Fig. 3. The relationship of prostaglandin E 1 (PGEr) to other prostagl-
andins. PG2 s have additionally a 5., 6-trans daub le band; PGFs 
have an a- or S-hydroxy instead of oxo at cai'bon 9; PGAs are 
dehydrated analogues of PGEs with a double bond between carbon 
10 and 11 in the ring. PGBs are not shown., but are isomers of 
PGAs with a double bond between carbon 8 and 12., instead of 
10 and 11. 
Unlike kinins, not all prostaglandins have similar actions (Horton, 
1969). Prostaglandin E1 resembles bradykinin in contracting the rat 
uterus and the guinea-pig ileum, and relaxing the rat duodenum, but 
differed from bradykinin in not relaxing the acetylcholine contracted 
guinea~pig ileum (Hall, unpublished observation). Both bradykinin 
and PGE 1 dilate the blood vessels of the rat hind limb, and increase 
the permeability of the capillaries of the guinea-pig skin (Horton, 
1963). An E-type prostaglandin has been found in the exudate during 
the secondary phase of the carrageenin oedema in the rat (Willis, 
1969), and also it is known that i.d. injections of PGE 1 or PGE 2 in 
rat or man produce inflammatory responses ( Crunkhorn and 1,-.Jillis, 
1971). Bradykinin and PGF2a both produce bronchoconstriction of the 
guinea-pig lungs (Collier and Shortley, 1960; Berry and Collier, 
1964). Antagonism of the bronchoconstriction induced by bradykinin 
has been demonstrated both in vitro and in vivo (Graeff and Moog, 
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1964; Collier and Shortley, 1963), also antagonism of the PGF2a 
contractions of the human isolated bronchial muscle (though not of 
the PGE 1 and PGE2 relaxations) has been demonstrated by the aspirin-
like drugs (Collier and Sweatman, 1968). These results together with 
the similarities between the actions of kinins and prostaglandins 
raised the question as to whether the non-steroidal anti-inflammatory 
drugs have their action by antagonizing the effects of PGF2a or an 
allied prostaglandin (Collier and Sweatman, 1968). During anaphylaxis 
of the guinea-pig lungs it was found that histamine, slow reacting 
substance in anaphylaxis (SRS-A), rabbit aorta contracting substance 
(RCS) and prostaglandins E2 and r 2a were released (Piper and Vane, 
1969). They also found that the release of RCS could be antagonized 
by the aspirin-like drugs. These same anti-inflammatory agents were 
found to interfere with the action of SRS-A (Berry and Collier, 1964) 
released during challenge of the isolated sensitized guinea-pig 
lungs, also arachidonic acid (Berry, 1966) and slow reacting substance-
C (SRS-C), produced when egg yolk lecithin or guinea-pig lung is 
challenged by venoms containing phospholipase-A (Vargaftig et al., 
1969). With the finding that arachidonic acid releases RCS from the 
isolated lungs, and that this release is also antagonized by the 
aspirin-like drugs (Vargaftig and Dao, 1971), it was suggested that 
RCS may be an intermediate in the synthesis of prostaglandins from 
arachidonic acid. It has now been demonstrated that synthesis of 
prostaglandins by homogenates of guinea-pig lung can be inhibited 
by the aspirin-like drugs {Vane, 1971); also, the adrenaline induced 
synthesis of prostaglandins in the isolated dog spleen (Ferreira et 
al., 1971); and the production of prostaglandins induced by thrombin 
in human platelets (Smith and Willis, 1971). The evidence points to 
the possibility of bradykinin being able to induce a release (de novo 
synthesis) of prostaglandin-like material from arachidonic acid or 
other precursors (Berry and Collier, 1964; Berry, 1966; Piper and 
Vane, 1969). The fact that the antagonistic activity of aspirin on 
prostaglandin synthesis parallels the anti-inflammatory activity in 
many situations argues strongly for a central position of prostaglan-
dins in the pathogenesis of inflammation. The direct activity of 
aspirin on the PGF2a contraction of isolated human bronchial muscle, 
appears to be contradictory to the above hypothesis, however Collier 
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(1971) believes this action to be a preferential reinforcement of 
antagonism against PGF2a distinct from PGE 1 and PGE 2 . 
THE ACTIONS OF BRADYKININ ON SMOOTH MUSCLE 
The subject matter has so far been limited to study of the various 
agents involved in the production of lesions on vascular and bronchial 
smooth muscle that give rise to the inflammatory response. To enable 
a fuller understanding an appraisal is also needed of the direct 
effects of bradykinin on vascular smooth muscle. 
A variety of responses have been found in vascular smooth muscle 
towards kinins. Kinins constrict the sheep coronary arteries (Koval-
~{k, 1962) and ductus arteriosus (Koval~ik, 1963), canine femoral and 
mesenteric arteries (De Pasquale and Burch, 1968), bovine pulmonary 
arteries (Klupp and Konzett, 1965), and the rabbit aorta, either nor-
mal or reserpinized (in vitro) (TUrker and Khairallah, 1966). In the 
case of the rabbit mesenteric vein strip, high concentrations of 
bradykinin contract but low concentrations transiently inhibit the 
spontaneous activity (Sutter, 1965; Somlyo and Somlyo, 1970). The 
canine large coronary arteries are also not contracted by bradykinin 
(KovalC{K,1962), and moreover the total perfused coronary bed under-
goes considerable vasodilatation (Antonio and Rocha e Silva, 1962). 
Of interest is the work of Somlyo and Somlyo (1970), who found that 
bradykinin relaxes small strips of rabbit mesenteric artery con-
tracted by noradrenaline. The most characteristic response of brady-
kinin in mammalian cutaneous, muscular and splanchnic beds is vaso-
dilatation. The vasodilator action of bradykinin is considered to be 
dirett, occuring in denervated vascular beds (Fregnan and Glasser, 
1968), after sympathetic blockade or atropine (Lloyd, 1962; Mason 
and Melman, 1965; Rosas et al., 1965), S-adrenergic blockers (Chou 
et al., 1965; Skinner and Powell, 1967; Skinner and Webster, 1968) 
and reserpinization (Miele and De Natale, 1966). The cellular mecha-
nisms of the vasodilator or constrictor actions of bradykinin, and 
a classification of the diverse actions is still unresolved. 
Besides vascular smooth muscle other smooth muscle preparations 
can be contracted by kinins, and in particular bradykinin. These 
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include the rat uterus and stomach fundus strip, the rabbit duodenum 
and large intestine, and the guinea-pig ileum (Rocha e Silva, 1970; 
Trautschold, 1970). The mechanism of the contraction of the isolated 
rat uterus and the guinea-pig ileu~ to synthetic bradykinin is thought 
to represent both a direct action of the kinin on the smooth muscle 
(Day and Vane, 1963; Khairallah and Page, 1963; \oliegershausen et al., 
1964; Gershon, 1967) and also indirectly via the release of acetyl-
choline (Wiegershausen et al., 1964). The former mechanism was pro-
posed since no other indirect mechanism could be demonstrated, and 
further that tetrodotoxin, eserine and hyoscine did not affect the 
maximal response with bradykinin. The latter mechanism was the result 
of the finding that contraction of the isolated guinea-pig ileum 
could be inhibited by atropine and morphine, and potentiated by 
eserine. The inhibition was manifested by a reduction and the poten-
tiation by an increase in the contraction speed of the organ. 
Although bradykinin is known to contract many smooth muscle pre-
parations, it is generally thought that, as exceptions, the rat 
duodenum (Elliot et al., 1960a) and the hen rectal caecum (ErdOs, 
1966) are relaxed. These effects have been considered to be one of 
the characteristic features of the pharmacology of bradykinin 
(Rocha e Silva, 1970). Indications are present in the literature that 
suggest bradykinin to be able to relax the rabbit duodenum (Fishlock, 
1966), the guinea-pig taenia coli (Regoli and Vane, 1964) and the rat 
ileum (Sherman a~d Gautieri, 1969). A sympathomimetic mechanism has 
been proposed for the bradykinin relaxation of the rat duodenum 
(TUrker et al., 1964; Montgomery, 1968), but evidence incompatible 
with this has been presented (Antonio, 1968). It has further been 
suggested that the bradykinin relaxation of the guinea-pig taenia 
coli is via an action on conducted impulses or spontaneous spike acti-
vity or both. This conclusion was derived from experinents using the 
sucrose gap technique, whereby bradykinin was shown to mainly suppress 
spontaneous spike activity, though did exhibit small hyperpolarizations 
(Aarsen a:1d Van Caspel-de Bruyn, 1970). 
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ANTAGONISM AND POTENTIATION OF BRADYKININ RESPONSES 
At this point in the introduction it would be instructive to 
discuss the current knowledge concerning antagonists of kinin respon-
ses on smooth muscle~ and also the range of drugs that are known to 
potentiate kinins. 
Antagonism 
There are unfortunately no known specific antagonists to brady-
kinin, even though intensive research activity has been devoted to 
the finding of one. However, an accumulation of information concerning 
drugs with some activity against bradykinin can be profitably dis~ 
cussed. Contraction of the guinea-pig ileum by bradykinin has been 
shown to be resistant to atropine, anti-histamines and paralyzing 
concentrations of nicotine (Ambache and Rocha e Silva, 1951; Werle, 
1955; Walaszek et al., 1963), and unaffected by morphine or BOL-148 
(Walaszek et al., 1963). However, as previously described, Wiegers-
hausen et al. (1964) found that contraction of the isolated guinea-
pig ileum could be inhibited by atropine and morphine, and potentiated 
by eserine. The inhibitory phase of bradykinin on the rabbit intestine 
is blocked by morphine, but not by atropine, local anaesthetics, 
adrenergic blockers, guanethidine or phenylbutazone. In the rat intes-
tine the inhibitory effect is not blocked by any of these agents or 
morphine (Bauer et al., 1966). 
Of the numerous compounds examined it has been reported that some 
phenothiazines, imipramine and cyproheptidine can act as antagonists 
(Rocha e Silva and Garcia Leme, 1963, 1964, 1965; Garcia Leme and 
Rocha e Silva, 1965). Also they reported that some dibenzocycloheptene 
derivatives were competitive antagonists, while benzodiazepine, cyclo-
alkindole and dibenzazepine derivatives acted as non- competitive anta-
gonists. Methixine was believed to be a competitive antagonist, but 
Van Riezen ( 1966) reports a non-competitive antagonism. The latter 
studies were on the guinea-pig ileum. 
Carboxypeptidase-B effectively antagonizes the actions of brady-
kinin in vivo (ErdOs et al., 1963). However the rationale of its 
action is rapid destruction of the kinins, rather than a direct action 
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on a receptor. The antagonistic action of some anti-inflammatory drugs 
on the bradykinin bronchoconstriction of the guinea-pig lungs is of 
great importance, and has been discussed elsewhere in the introduction. 
Potentiation 
Many compounds are known to potentiate the actions of bradykinin. 
One such group of agents consists of the thiol compounds. These in-
clude cysteine, a-thiol glycerol, 2-mercaptoethanol, 2,3-dimercapto-
propanol (BAL) and thioglycolic acid (Ferreira and Rocha e Silva, 
1962; Picarelli et al., 1962; ErdOs and Wohler, 1963a,b). All these 
compounds can inhibit the enzymatic breakdown of kinins, and it is 
thought that their in vivo effects are related to this (ErdOs and 
Wohler, 1963a,b). With isolated smooth muscle preparations the mecha-
nism is uncertain, there existing evidence that the effect of brady-
kinin is potentiated by a direct action on the muscle. Much evidence 
for a direct potentiating action of thiols on isolated smooth muscle 
preparations has been proposed (Cirstea, 1965; Doleschel and Auers-
wald, 1966; Auerswald and Doleschel, 1967; Tewksbury, 1967). More 
recently a cholinergic mechanism has been suggested (Potter and 
Walaszek, 1972). In the same way that thiol compounds potentiate the 
effects of bradykinin, a bradykinin potentiating factor (BPF) isolated 
from the venom of Bothrops jararaca (Ferreira and Rocha e .Silva, 1962; 
Ferreira, 1965) has also been found to be active. BAL and BPF have 
recently been examined on the relaxation and contraction responses 
of the rat intestine by bradykinin (Camargo and Ferreira, 1971). No 
potentiation was found of the relaxation. The authors regard their 
results as an indication of separate receptors for contraction and 
relaxation. 
Potentiation of the bradykinin contraction of the guinea-pig ileum 
can also be demonstrated with the local anaesthetic, procaine, though 
cocaine and tetracaine only sensitized the ileum to further doses of 
bradykinin (Wiegershausen et al., 1973). Various proteins e.g. chymo-
trypsin and trypsin are also able to potentiate the action of brady-
kinin on the guinea-pig ileum and the rat uterus (Edery, 1964, 1965). 
It seems to be quite specific for kinins, though the mechanism is un-
known. In a recent paper the action of chymotrypsin was regarded to 
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be sensitization rather than potentiation (Wiegershausen et al., 
1973). It is also known that the guinea-pig ileum can be sensitized 
to the action of bradykinin by trypsin hydrolysates of ox and rabbit 
plasma (Aarsen, 1968) and the rat uterus by peptide-B, produced by 
the action of thrombin and bovine fibrinogen (Gladner et al., 1963; 
Gladner, 1966). These peptides may be of importance in sensitizing 
tissue receptors to bradykinin. 
SOME IDEAS AND OBSERVATIONS 
The involvement of catecholamines in the inflammatory responses 
has been treated in earlier sections. The precise nature of the me-
chanism is unknown, and also if catecholamines are pro- or anti-in-
flammatory substances. It seemed that the mechanism of the possible 
interactions between bradykinin and catecholamines could be a fruitful 
area of research. 
Evidence is available suggesting that catecholamines can assist 
or potentiate the activities of kinins (Rocha e Silva et al., 1960; 
Lloyd, 1962; Di Mattei, 1963; Nakano, 1965; Bonta and De Vos, 1966; 
James, 1969), though equally there is evidence suggesting catechola-
mines to have an anti-inflammatory (anti-bradykinin?) action (Spector 
and Willoughby, 1960; Northover, 1963; Willoughby and Spector, 1964; 
Brown and West, 1965; Northover and Subramamian, 1966). It has been 
further suggested that the anti-inflammatory activity of catechola-
mines is mediated entirely through their hyperglycaemic action (Kel-
lett, 1965). It is now well established that the hyperglycaemic action 
of adrenaline is due to stimulation of the rate of formation of adeno-
sine 3' ,5'-cyclic monophospate (cyclic AMP), which in turn increases 
the rate of formation of active phosphorylase (Robison et al., 1968). 
There is an accumulation of evidence, albei~ mostly indirect, that 
cyclic AMP could play a role in the inflammatory response. The S-
adrenergic blocker, dichloroisoprenaline, was found to decrease the 
isoprenaline reduction of the formaldehyde oedema in the mouse pal-.', 
but not of the reduction due to noradrenaline and phenylephrine 
(Northover and Subramamian,J962). It has also been sho~>m that the 
adrenaline reduction of the dextran oedema in the rat paw is anta-
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gonized by the S-adrenergic blocker, sotalol (McKinney and Lish, 
1966), and that sotalol also blocked the catecholamine reduction of 
the formaldehyde oedema in rats (Brown et al., 1968). Catecholamine 
antagonism of the various oedemas appears to be via a stimulation of 
S-adrenergic receptors. There is strong evidence to suggest that the 
enzyme adenyl cyclase (the en~me responsible for the formation of 
cyclic AMP from ATP) fits the definition of a S-adrenergic receptor. 
The studies that support this concept come from liver, heart, brain 
and avian erythrocytes (Robison et al., 1968). Studies on smooth 
muscle systems are, on the whole, compatible with the hypothesis 
that the relaxing effect of catecholamines is mediated by adrenergic 
receptors, and is related to increases in the levels of cyclic AMP. 
The hypothesis has been extended to non-adrenergic systems, since 
papavarine, a smooth muscle depressant, inhibited the action of 
phosphodiesterase (the enzyme that degrades cyclic AMP) thus allowing 
an increase in cyclic AMP (Triner et al., 1970; Kukovetz and POch, 
1970). These results might well be extended to vascular smooth muscle. 
Direct evidence implicating cyclic AMP as a local anti-inflammatory 
hormone has come from experiments using theophylline (a phosphodies-
terase inhibitor) and cyclic AMP, where both agents were shown to 
display clear cut dose-related anti-inflammatory activity on the 
carrageenin, dextran and egg white oedemas of the rat paw (Bertelli 
et al., 1966). 
ATP (the precursor of cyclic AMP) has also been shown to be active 
in causing bronchoconstriction of the guinea-pig lungs (Collier and 
Shortley, 1963), and as with bradykinin and SRS-A the action is blocked 
by low doses of aspirin. Perfusion of the unsensitized guinea-pig 
lungs with ATP did not result in the release of RCS or prostaglandins, 
as is found with bradykinin and SRS-A, or in anaphylaxis (Piper and 
Vane, 1969). These results suggest that aspirin does not block the 
action of ATP by a mechanism involving the inhibition of the synthesis 
of prostaglandins (Vane, 1971). Aspirin may interfere directly with 
ATP, though it is possible that ATP must first be converted into an 
active principle (cyclic AMP?). 
The results so far described prompted a consideration of the fac-
tors that may be interrelated between the catecholamines and brady-
kinin with particular reference to cyclic AMP. As a starting point 
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for experimentation it seemed more feasible to study a relatively 
simple system, as opposed to the complexities of the inflammatory 
syndrome. Of the systems available where it is known that bradykinin 
and catecholamines show activity, is smooth muscle, which is also 
desirable on account of its connection with inflammation. Another 
advantage of the use of smooth muscle preparations is that the various 
parameters can be rigidly controlled, allowing more precise and de-
tailed investigations. Initially the rat uterus and the guinea-pig 
ileum were chosen, to examine the influence of the cyclic AMP system. 
Unfortunately no significant effects of increased cyclic AMP levels 
on the bradykinin responses were found. One of the experimental con-
ditions that was employed required the depletion of tissue cyclic 
AMP by incubation with imidazole (Robison et al., 1968). Under this 
condition a sustained contraction of the guinea-pig ileum was ob-
served. Subsequent addition of bradykinin to this organ, now with 
increased tone, resulted in the appearance of a small relaxation 
immediately followed by a contraction. This small bradykinin relaxa-
tion provoked considerable curiosity. Relaxation of the guinea-pig 
ileum does not seem to have been previously reported for bradykinin. 
As a first step in the characterization of this bradykinin relaxation 
response, the ileum was challenged by acetylcholine, which resulted 
in a maintained contraction. On further addition of bradykinin a 
biphasic response was seen, first a relaxation immediately followed 
by a contraction. An investigation into this hitherto unknown brady-
kinin relaxation on intestinal smooth muscle may lead to results 
applicable to vascular smooth muscle and allow the development of a 
model for some of the actions of bradykinin in inflammation. 
The present investigations have examined the conditions for and 
characteristics of the bradykinin relaxation of the isolated guinea-
pig ileum. The involvement of catecholamines and prostaglandins has 
also been examined, and further some potentiators of this previously 
unknown response. 
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Chapter 2 
THE BIPHASIC RESPONSE OF THE ISOLATED GUINEA-PIG ILEUM BY BRADYKININ 
SUMMARY 
The isolated guinea-pig ileum, challenged by spasmogens, was used 
to study the effect of bradykinin. In the presence of acetylcholine 
producing approximately 60 % of maximum contraction, bradykinin 
caused relaxation followed by contraction. The biphasic response to 
bradykinin was also found in the presence of histamine, eledoisin, 
angiotensin, prostaglandin F2a and transmural electrical stimulation. 
The conditions for bradykinin-induced relaxation were not found after 
contraction by bradykinin, and potassium or barium chloride. Under 
conditions where bradykinin produced a biphasic response, acetylcho-
line, histamine, eledoisin, angiotensin, prostaglandin r 2a and lysine 
vasopressin only contracted the ileum, while adrenaline, noradrena-
line, oxytocin, calcium and magnesium chloride only relaxed. On in-
creasing the percentage of maximum contraction of the ileum with 
acetylcholine, a linear inverse relationship with relaxa~ion by 
bradykinin was found. Tachyphylaxis was not present with the brady-
kinin-induced relaxation. The relaxing effect of bradykinin is more 
likely to be due to a direct action on the muscle cell membrane than 
to a release of a mediator or to blockade of a recep~or mediating 
contraction. 
INTRODUCTION 
Bradykinin has been shown to produce a slow contraction of many 
intestinal smooth muscle preparations, including the rat fund'-.ls strip, 
rabbit duodenum and large intestine, and the guinea-pig ileum (Rocha 
e Silva, 1970; Trautschold, 1970). The mechanism for the guinea-pig 
ileum has been thought to represent a direct action of the kinin on 
the smooth muscle (Day and Vane, 1963; Khairallah and Page, 1963; 
Wiegershausen et al., 1964; Gershon, 1967) and also indirectly via 
the release of acetylcholine (Wiegershausen et al., 1964). The former 
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mechanism was proposed since no other indirect mechanism could be 
demonstrated and further that tetrodotoxin, eserine and hyoscine did 
not affect the maximal response with bradykinin. The latter indirect 
mechanism was the result of the finding that contraction of the 
isolated guinea-pig ileum could be inhibited by atropine and morphine, 
and potentiated by eserine. The inhibition was manifested by a re-
duction and the potentiation by an increase in the contraction speed 
ofilie~-. 
Apart from the contractile effects of bradykinin on intestinal 
smooth muscle, it is also known that the rat duodenum is relaxed by 
bradykinin (Elliot et al., 1960; Antonio, 1968). The effect on this 
organ is thought to be one of the characteristic features of the 
pharmacology of bradykinin (Rocha e Silva, 1970), however indications 
have been found in the literature which suggest that bradykinin can 
also relax the rabbit duodenum and rat colon (Elliot et al., 1960), 
the human small and large intestine (Fishlock, 1966), the guinea-pig 
taenia coli (Regoli and Vane, 1964), the hen rectal caecum (ErdOs, 
1966) and the rat ileum (Sherman and Gautieri, 1969). These results 
stress the importance of not only considering the contractile effects 
of bradykinin on smooth muscle, but also a possible ubiquitous relaxa-
tion component before the contraction by bradykinin on smooth muscle. 
To our knowledge relaxation of the guinea-pig ileum by bradykinin 
has never been previously demonstrated. We observed this response 
first during experiments designed to establish a relationship between 
cyclic-3', 5'-AMP and the bradykinin contraction. In an attempt to 
stimulate the action of phosphodiesterase the ileum was preincubated 
with imidazole (Robison et al., 1968), which caused a sustained con-
traction of the ileum. Addition of bradykinin resulted in a biphasic 
response, first a relaxation, then a contraction. The relaxation 
provoked considerable interest and was accordingly quantified, but 
using acetylcholine in place of imidazole to contract the ileum. In 
this chapter are described some Conditions under which the guinea-pig 
ileum can be relaxed by bradykinin, and also some of the properties 
of this relaxation. 
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MATERIALS AND METHODS 
Female guinea-pigs weighing between 200-250 g were sacrificed by 
decapitation and bleeding. The abdominal cavity was exposed and the 
entire small intestine removed. The terminal ileum, taken to be the 
10 em immediately before the caecum, was discarded and a piece of 
ileum approximately 2 em long adjacent to the terminal section was 
washed in warm Tyrode solution. Taenia coli strips of 2 em length 
were taken from the large intestine. The organs were suspended in 
a 5-ml organ bath at 37°C, and gassed with air. Changes in the length 
of the preparations were detected by a Harvard Heart/Smooth Muscle 
Transducer (Model 356) with a total load on the organ of 0.5 g and 
recorded by a Harvard Electronic Recording Module (Model 350). 
Two platinum electrodes were arranged for transmural stimulation, when 
required, and stimulation was given by a Grass Model S 6 stimulator, 
which had been converted to give a low frequency of 40mHz in place 
of 2Hz. 
The Tyrode solution had the following composition g/1 in deionized 
water: NaCl 8.00, KCl 0.20, CaCl 2 0.20, MgC12 0.10, NaHC0 3 1.00, NaH2-
P04 0.05, glucose 1.00. The following drugs were used: synthetic 
bradykinin (Sandoz, Switzerland) prepared in 10 Wg freeze-dried 
samples (Organon, Holland) with a binding medium of the following 
composition: toluene-4-sulphonic acid 0.1 mg, gelatin (Hydrolysate) 
1 mg, mannitol 15 mg; acetylcholine chloride (Merck, Germany); 
histamine dichloride, !-adrenaline bitartrate, !-noradrenaline hydro-
R . 
chloride (Fluka, Switzerland); angiotensin (Hypertensin , CIBA-Gelgy, 
Switzerland), Prostaglandin r 2a was kindly donated by Upjohn U.S.A., 
synthetic oxytocin and lysine vasopressin by Organon, Holland and 
eledoisin trifluoracetate by Sandoz, Switzerland. All drugs were dis-
solved in Tyrode solution and doses refer to their salts. Other che-
micals used were of analytical grade. 
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RESULTS 
Dose-response relationships 
In the experiments to be described acetylcholine was added at a 
concentration of between 10-20 ng/ml, depending on the sensitivity 
and length of the ileum to produce approximately 60 % of the maximum 
contraction, and 1 min thereafter was added bradykinin at a concen-
tration ranging between 1-100 ng/ml depending on the circumstances 
of the experiment. Bradykinin was allowed to remain in contact with 
the organ for 40 sec before washing out. Further additions were made 
in 4-min cycles. At low concentrations of bradykinin (1-4 ng/ml) a 
linear relaxation dose-response curve could be constructed (figs. 1 
and 2), the response being measured from the elevated base line to 
BR BR BR BR BR 
1 2 3 4 6 
"1 "\;./ ~,r ~("' "'i·~ .r 
' 
\ 
__j \ e--H __j __j _j __\ • • • • • 1min. 
Ach Ach Ach Ach Ach 
20 20 20 20 20 
Fig. 1. Effect of increasing doses of bradykinin (BR) on the guinea-pig 
ileum added 1 min after doses of acetylcholine (Ach) producing 
ohout 60% maximwn contraction. Bradykinin was in contact with 
the ileum 40 sec before washing out. Nwribers relate to ng/ml. 
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Fig. 2. Dose-response reZationships for the reZaxation (soZid tine) and 
contraction (broken Une) of the guinea-pig {Zewn by bradykinin 
added 1 min after the addition of acetylchoUne~ 20 ng/mZ~ 
producing about 60% maximum contraction. Points with a vertical 
Une (S.E.M.) represent 8 experiments~ while other points are 
the mean of two experiments. Relaxation and contraction responses 
were measured at the same time on the same ileum after acetyl-
choZine. 
the deepest point of the relaxation. At concentrations of bradykinin 
above 4 ng/ml the relaxation dose-response curve became non-linear, 
and as can be seen from fig. 2 contractions were produced at concen-
trations greater than 4 ng/ml. 
Spee:ifie:i ty of the bradykinin relaxation 
It was considered that the relaxation of the acetylcholine con-
tracted guinea-pig ileum may not be a specific property of bradykinin. 
To this end some biologically active substances were examined under 
the same conditions. These results are shown in fig. 3. Both noradre-
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Fig. 3. Effect of bradykinin (BR)~ noradrenaline (NA), adrenaline (Ad), 
calcium chloride (Ca), magnesium chloride (Mg), oxytocin (Ox) 
and lysine vasopressin (V) on the guinea-pig ileum, added 1 min 
after doses of acetylcholine (Ach) producing about 60% maximum 
contraction. Acetylcholine was in contact with the iZewn 1 min 
40 sec before washing out. Numbers relate to ng/ml, unless 
speeified. 
naline and adrenaline (2~g/ml) relaxed the acetylcholine contracted 
ileum, but differed from bradykinin in that their relaxations were 
maintained i.e. there was no recovery from the relaxation to the e~e-
2+ 
vated base line (fig. 3a). A similar result was found with 3.6 mM Ca 
and 2.0 mM Mg2+ (fig. 3b). Oxytocin produced only a relaxation at 
400 miU/ml, while lys-vasopressin produced a small contraction at 
10 Wg/ml (fig. 3c). Acetylcholine, 1-20 ng/ml, histamine, 1-20 ng/rnl, 
eledoisin, 1-200 ng/rnl, prostaglandin F2a• 200-1000 ng/rnl and angioten-
sin, 1-200 ng/ml produced only contraction responses after the stan-
dard contraction with acetylcholine. The carrier medium for bradykinin 
produced no effect at 100 times the normal bath concentration. The 
latter figures are not included for the sake of brevity. Initial 
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investigation of the guinea-pig taenia coli has brought to light a 
different result with angiotensin (fig. 4). It can be seen on in-
creasing the angiotensin concentration between 4-400 ng/ml the 
appearance of a biphasic response. It can also be observed that the 
taenia coli is 10 or more times less active towards relaxation by 
angiotensin, while 10 or more times more active to contraction by 
angiotensin than bradykinin. 
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Fig. 4. Effect of bradykinin (BR) and angiotensin (Ang) added 1 min 
after acetylcholine (Ach)~ 10 ng/ml~ contractions of the guinea-
pig taenia coli. Acetylcholine ZJas in contac:t with the taenia 
coli 1 min 40 sec before washing out. Numbers relate to ng/ml. 
Conditions for the bradykinin relaxation 
These experiments were designed to show whether the relaxation 
response is dependent on any one particular type of receptor. Various 
spasmogens of a dissimilar nature were given to the ileum in place 
of acetylcholine, the doses chosen such that an approximately 60% 
maximum contraction of the spasmogen contraction was obtained. By 
this means conditions imitating acetylcholine were achieved (Fig. 5). 
It can be observed that histamine at doses of 40 ng/ml and angiotensin, 
2 ng/ml, provided the necessary conditions for relaxation (fig. Sa). 
After histamine the relaxation was similar, but after angiotensin it 
was reduced and a contraction became evident. With eledoisin, 2 ng/ml, 
and prostaglandin r 2a, 500 ng/ml, the conditions for the relaxation 
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Fig. 5. Effect of a standard dose of bradykinin (BR) on the guinea-pig 
ileum, added 1 min after acetylchol-ine (Ach), histarrri.ne (H), 
angiotensin (Ang)~ el~doisin (E) and prostaglandin F2 (P), potassium chloride (K) and barium chloride (Ba++) prgducing 
approximately the same percentage of maximum contraction as 
acetylcholine. Bradykinin was in contact with the ileum 40 sec 
before washing out. Numbers relate to ng/ml, unless specified. 
lbl 
were also met (fig. Sb), however with eledoisin the bradykinin relaxa-
tion was larger than that after the standard acetylcholine contraction. 
This observation could be repeatedly demonstrated using different ilea. 
When potassium chloride, 56.3 mM, or barium chloride, 9.6 mM, was in 
place of acetylcholine (fig. 5c), the ileum displayed an initial 
spike followed by a slow maintained contraction. No relaxation was 
found with bradykinin after either, but in their place was a small 
contraction. Similar results were also found with 125.4 mM and 158.0 
mM potassium chloride. In the case of the transmurally stimulated ileum 
(20V, 10 msec, 0.36 Hz) increasing doses of bradykinin in the range 
0.5 - 3.0 ng/ml resulted in increasing relaxations (fig. 6). A con-
centration of 4 ng/ml did not produce a lir.ear response, and on 
occasions a small contraction resulted. 
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Fig. 6. Effect of various doses of bradykinin (BR) added to the trans-
rnu.rally stimulated guinea-pig ilewn. Stirrn<.lation was at 20 V. .. 
10 msec~ 0. 36 Hz. Bradykinin was in contact with the ileum 40 
sec before washing out. Numbers relate to ng/ml. 
Va:riation in acety Zcholine concentration 
If the concentration of challenging acetylcholine was increased 
then the elevated base line also increased. On raising the acetyl-
choline base line, which is conveniently expressed as the percentage 
of the maximum acetylcholine contraction, the relaxation produced by 
bradykinin can be seen to decrease (table 1). The equations for the 
variation in the percentage of maximum contraction with acetylcholine 
and the bradykinin relaxation are depicted in fig. 7. Calculations 
using these regression equations are found in subsequent chapters. 
The sensitivity of the recording module was constant throughout the 
experiments, however the base line for measurement of contraction was 
adjusted by vertical displacement of the transducer at each acetyl-
choline concentration, thus allowing the relaxations to be measured on 
the chart. The maximal contraction can be estimated in the region of 
125 mm at this sensitivity. 
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Table 1 
The effect of the increase in acetylcholine concentration and percent-
age of maximal contraction of the guinea-pig ileum on the relaxation 
produced by a constant dose of bradykinin. 
Acetylcholine concentration Maximal contraction Bradykinin*relaxation 
ng/ml ~ S.E.M. (%) ~ S.E.M. {mm) 
10 28 + J 43.0:::0.7 (6) .. 
20 63 + 3 21.6::: 1.2 (11) 
40 85 + 4 8.8:::0.6 (5) 
100 100 + 2 1.9:::0.2 (5) 
200 100+2 1.0:::0.0 (5) 
. Bradykinin, 2 ng/ml 
**Numbers of experiments in parenthesis. The correlation coefficient (r) 
between the log 10 acetylcholine concentration and the bradykinin relax-
ation was- 0.923, The linear regression equation was y =- 0,16x 1 + 
27.36, where y =bradykinin relaxation (mm) and x1 = log 10 acetylcholine 
concentration. The correlation coefficient (r) between the % maximal 
contraction and the bradykinin relaxation was- 0.999. The linear 
regression equation was y =- 0.58x + 58.62, where y ""bradykinin 
relaxation (mm) and x =% maximal contraction. 
'_. maximum 
con,ac,;on 
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0
0 moximu"' contmotion 
v'< ocetykholine 
bradykinin 
relaxolion "'"' 
0
o maximum cOntraction 
v'> bradykinin 
10 20 40 100 200 000 1000 acetylcholine 
~-~--~---~-~--~--~ ngi-nl 
100 bradykinin relaxation 
Fig. 7. Effect of varying the chal~nging acetylcholine concentration~ 
and the percentage of maximum contraction using acetylcholine 
on the bradykinin relaxation (2 ng/ml) of the guinea-pig ileum. 
Open squraes: Percentage of maxirrrwn contraction plotted against 
acetylcholine concentration. 
Solid triangles: BradYkinin relaxation plotted against acetyl-
choline concentration. 
Solid ciroles: Percentage of maximum contraction plotted against 
bradYkinin relaxation. 
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Table 2 
The effect of bradykinin pretreatment on the bradykinin relaxation of 
the acetylcholine contracted guinea-pig ileum. 
BR 
2 
Ach 
10 
Bradykinin added* Bradykinin relaxtion** 
Controls Bradykinin pretreated 
(ng/ml) mm + S.E.M. mm + S.E.M, 
0.1 25.9+1.1 19,7::: 1.0 (5)" 
0.2 25.0 + 0,8 16.3 ::: 1.2 (5)" 
1.0 24.8 + 1.1 9,6:::0.3 (5)" 
2.0 25,4 + 2.3 6.0 ::: o. 9 (7)" 
* Bradykinin was added 1 min before acetylcholine (20 ng/ml). 
** Bradykinin, 2 ng/ml. 
.6. Numbers of experiments in parentheses. p.s;;;: 0.01 (Student's t-test). 
The correlation coefficient (r) between the log 10 bradykinin 
concentration and the bradykinin relaxation was- 0.999o 
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Fig. B. Pretreatment of the guinea-pig ileum by bradykinin (BR); 
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a) Effect of a non-contracting dose of bradykinin added 1 rrrin 
before a dose of acetylcholine (Ach), 10 ng/ml, on the relax-
ation produced by bradykinin 1 min after the acetyLchoLine. 
b) Effect of a cont:racting dose of bradykinin-3 40 ng/ml-3 on the 
reLaxation produced by a further non-contracting dose of 
bradykinin in the absence of acetylcholine. 
c) Effect of cumuLative sub-maximal. reLaxation doses of brady-
kinin) added after the standard acetyLchoLine contraction. 
d) Effect of cumulative sub-maximal relaxation doses of brady-
kinin added during transmural stimul.ation-3 20 V-3 10 msec-3 
0. 36 Hz. 
Nv.mbers relate to ng/mZ. 
Action of bradykinin on its own response 
Addition of bradykinin 1 min before the standard acetylcholine 
contraction resulted in a reduction of the subsequent bradykinin re-
laxation (fig. Ba). On varying the concentration of bradykinin in the 
range 0.1-2.0 ng/rnl there resulted a dose dependent relationship where 
the correlation coefficient (r) was 0.999 (table 2). When bradykinin 
(40 ng/ml) was given to the ileum in place of acetylcholine there was 
a sustained contraction (fig. Bb). The relaxation of a further dose of 
bradykinin (2 ng/rnl) was prevented and in its place a small contraction 
was observed. Furthe~ if a dose of bradykinin giving sub-maximal relaxa-
tion responses was given 1 min after a standard acetylcholine contrac-
tion and bradykinin, 2 ng/ml (fig. Be) or 1.5 min after a sub-maximal 
relaxation dose of bradykinin, 2 ng/ml, on the transmurally stimulated 
ileum (fig. Bd), the relaxation response of bradykinin was seen to be 
greatly diminished. 
DISCUSSION 
In the system used for this investigation it is possible to record 
both an initial relaxation and a further contraction. At lower doses 
of bradykinin 1-4 ng/ml a dose-response curve could be constructed, but 
at higher concentrations the curve became non-linear and even decreased. 
At a threshold concentration of 4 ng/ml for these preparations a con-
traction response became evident. From the experiments described in 
this chapter the sensitivity of the bradykinin relaxation was apparent-
ly of the same order as that of the contraction of the rat uterus or 
the relaxation of the rat duodenum (Rocha e Silva, 1970). 
The relaxation found with bradykinin on the guinea-pig ileum when 
compared to that of adrenaline, noradrenaline, calcium, magnesium or 
oxytocin shows a remarkedly different form. With the latter substances 
the guinea-pig ileum responds only with relaxation, without the con-
comitant return to the original elevated base line, or with larger 
concentrations of bradykinin, contractions. Of the other biologically 
active substances examined only contraction responses were found. These 
results indicate that the property of relaxation, folloHed by contrac-
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tion of the acetylcholine contracted guinea-pig ileum is probably 
specific to bradykinin. 
Similarities in the actions of bradykinin and angiotensin have 
been previously reported on the superior cervical ganglion of the cat 
(Lewis and Reit, 1965) and the central nervous system of the cat 
(~apek et al., 1969). The finding that angiotensin first relaxes then 
contracts the guinea-pig taenia coli at concentrations greater than 
40 ng/ml suggests there may be a similarity of action of these peptides 
in giving relaxation of this organ. It can also be seen that for re-
laxation bradykinin is about 40 times more active on the ileum than 
on the taenia coli. These results are however only qualitative, a more 
detailed investigation being necessary before a full comparison of 
these peptides can be made. 
It appears possible to use not only acetylcholine as the initial 
challenging spasmogen but also histamine, eledoisin, angiotensin and 
prostaglandin r 2a. After angiotensin there results a smaller relaxa-
tion with bradykinin, than after acetylcholine. An explanation might 
be that if angiotensin has a slight bradykinin-like activity, but not 
enough to elicit a visual relaxation of the guinea-pig ileum, it may 
still function like bradykinin in inhibiting its own relaxation res-
ponse. After eledoisin, bradykinin can be seen to produce a larger re-
laxation than after acetylcholine. No explanation can be given for 
these phenomena at the present time but these questions are further 
discussed in chapter 4. Transmural stimulation also provides the con-
ditions for relaxation of the guinea-pig ileum. Evidence suggests that 
this stimulation contracts the organ via excitation of the postganglio-
nic cholinergic fibres and also via a direct action on the effector 
cell structures (Paton, 1955). From these combined results it would 
appear improbable that bradykinin is having any transient blocking 
activity on any of the known receptors, since no common receptor is 
involved in contraction by any of the previous spasmogens used. 
Smooth muscle depolarized by potassium rich solutions can be con-
tracted and relaxed by drugs, the responses being uncomplicated by 
their effects on membrane depolarization and electrical conduction 
(Schild, 1964). The guinea-pig ileum when treated with the various 
potassium concentrations undergoes first a brief contraction followed 
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by relaxation, then forms a maintained elevated base line. The main-
tained contraction is considered to be dependent on the calcium con-
tent of the bathing medium (Durbin and Jenkinson, 1961). A fully depo-
larizing potassium concentration was taken to be 158 mM. This con-
centration is within the range used by various authors (Durbin and 
Jenkinson, 1961; Edman and Schild, 1963). No concentrations of potas-
sium chloride examined gave the correct conditions for the bradykinin 
relaxation, even though the lower concentrations were not fully depo-
larizing. It can also be observed that increasing the degree of con-
traction of the ileum with acetylcholine gives a progressive reduction 
in the bradykinin relaxation and so does not provide the correct con-
ditions. These results were found to have a correlation coefficient 
(r) of- 0.999, suggesting an almost perfect inverse linear relation-
ship between the two parameters. It is possible that increasing the 
acetylcholine concentration to give maximal contractions produces a 
similar effect as depolarizing concentrations of potassium chloride. 
These results with increasing concentrations of acetylcholine and 
depolarizing potassium chloride solutions can be taken in conjunction 
with those of Antonio (1968) on the isolated rat duodenum. When he 
used 42 mM potassium chloride he found that the bradykinin relaxation 
was eliminated and in its place was a small contraction which was 
unrelated to the dose of bradykinin. In the present experiments higher 
concentrations were found to give a similar result. He also found a 
concentration of acetylcholine, 1 ~g/rnl, reduced the bradykinin re-
laxation at calcium concentrations between 0.25 - 8.0 mM. This acetyl-
choline concentration is 10 times that which almost completely elimi-
nates the bradykinin relaxation on the guinea-pig ileum. Barium ions 
were thought to contract intestinal smooth muscle indirectly through 
the cholinergic nerve elements (Innes et al., 1957), but barium con-
tractions have been recently shown to be insensitive to atropine, hemi-
cholinium and hexamethonium (Shibata et al., 1970). It seems probable 
that barium induced contractions are mediated by membrane potential 
changes such as depolarization (Suzuki et al., 1964), and that there 
is a specific site of action for barium ions (Takagi and Takayanagi, 
1962). In the former respect the action of barium resembles that of 
potassium ions in depolarizing the ileum. These results suggest that 
bradykinin has no influence on the processes mediating drug-induced 
55 
contraction in the presence of fully depolarizing concentrations of K+ 
or Ba++, but rather has a direct influence on the properties of the 
muscle cell membrane. Bradykinin can be thought of to act on either the 
inhibition of conducted impulses or spike activity or both. Recent 
work on the guinea-pig taenia coli (Aarsen and Van Caspel-de Bruyn, 
1970) using the sucrose gap technique showed that bradykinin mainly 
suppressed spike activity, but also exhibited very small hyperpolari-
zations. They implicate Ca2+ since under normal conditions these ions 
have been found to carry most of the current during the action poten-
tial (Blllbring and Kuriyama, 1963). 
The necessary conditions for relaxation were also not provided by 
a contracting dose of bradykinin. Not only did this dose of bradykinin 
not provide the correct conditions, but also non-contracting doses 
given before a constant amount of acetylcholine prevented the relaxation 
response in a dose-dependent manner. It can also be seen that a 
submaximal dose of bradykinin given after acetylcholine prevented the 
relaxation produced by a similar dose. This was found irrespective 
of the fact that the ileum was challenged first by acetylcholine or 
stimulated transmurally. In the light of the definition for tachy-
phylaxis (Bowman et al., 1969), one can see that the conditions are 
not satisfied, since bradykinin is not washed out after each addition. 
Also it can be said that at no time during the course of an experiment 
or series of experiments on the same ileum were there diminishing 
bradykinin relaxation responses observed. It is thus unlikely that 
bradykinin is releasing a mediator from stores e.g. catecholamines. 
Continual release of a stored mediator by bradykinin over a period of 
hours should ultimately results in a diminished response, which is 
not found. If a receptor exists for the relaxation with bradykinin, 
then it appears that bradykinin has the ability to either saturate the 
receptor at very low concentrations or to alter the confirmation of 
the membrane as to preclude further binding of the bradykinin to the 
existing free receptors. The latter hypothesis seems more likely, 
since even sub-maximal doses can be shown to antagonize each other, 
where there is unlikely to be full receptor saturation. 
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Chapter 3 
EFFECTS OF ADRENERGIC BLOCKERS ON THE RELAXATION OF 
THE GUINEA-PIG ILEUM BY BRADYKININ AND ADRENALINE 
SUMMARY 
Some a- and 6-adrenergic blockers have been examined on the brady-
kinin-and adrenaline-induced relaxation of the acetylcholine contrac-
ted guinea-pig ileum. The a- adrenergic blocker piperoxan potentiated, 
while phentolamine reduced the bradykinin relaxation. Both reduced 
the acetylcholine contraction, but had no effect on the adrenaline 
relaxation. The bradykinin relaxation of the guinea-pig ileum was 
about ten times more sensitive to phentolamine than the rat duodenum. 
The 6-adrenergic blocker propranolol potentiated the bradykinin 
relaxation and reduced the acetylcholine contraction. Sotalol was in 
these respects less potent than propranolol. The adrenaline relaxation 
was partially blocked by propranolol, but almost completely by sotalol. 
A combination of phentolamine and propranolol slightly potentiated 
the bradykinin relaxation, and partially blocked the adrenaline relaxa-
tion. The bradykinin relaxation is not due to a direct action on either 
the a- or 6- adrenergic receptors of the guinea-pig ileum. The poten-
tiation of the bradykinin relaxation is probably indirect via the re-
duction of the acetylcholine contraction. The action of phentolamine 
cannot be explained by this mechanism. Seemingly only 6- adrenergic 
receptor activity mediates relaxation with adrenaline. 
INTRODUCTION 
Bradykinin is known to liberate adrenaline from the adrenal medulla 
(Lecompte et al., 1961; Feldberg and Lewis, 1964) and also to stimulate 
the sympathetic ganglia (Lewis and Reit, 1965). In the latter respect 
it resembles non-nicotinic ganglion stimulants (Lewis and Reit, 1966; 
Trendelenburg, 1966). Adrenergic blockade and adrenalectomy are known 
to potentiate the hypotensive (Rocha e Silva et al., 1960; Lloyd, 1962; 
Nakano, 1965) and the bronchoconstrictor (James, 1969) actions of 
bradykinin. 
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Some work has been devoted to examining these sympathomimetic 
effects of bradykinin on isolated smooth muscle preparations. The rat 
duodenum has been exclusively studied, since it may be relaxed with 
bradykinin at nanogram concentrations (Elliot et al., 1960) and this 
relaxation resembles sympathetic stimulation (Antonio, 1968). It is 
also known that stimulation of both a- and s-adrenergic receptors 
of intestinal smooth muscle by catecholamines results in relaxation 
(Brody and Diamond, 1967; Jenkinson and Morton, 1967). Some authors 
favour a sympathomimetic mechanism for the relaxation of the rat duo-
denum (TUrker et al., 1964; Montgomery, 1968), but evidence incompa-
tible with this hypothesis has also been presented (Antonio, 1968). 
The finding that bradykinin can under suitable conditions relax 
the guinea-pig ileum (chapter 2) prompted an investigation into the 
possible sympathomimetic properties of bradykinin on this organ. The 
conditions that have been found suitable for the relaxation are the 
addition of bradykinin in the presence of contraction by low concen-
trations of acetylcholine and other agonists. In this study the hypo-
thesis has been considered that bradykinin releases catecholamines 
from stores onto either the a- or S-adrenergic receptors, or has a 
direct action on the same receptors to mediate relaxation. 
MATERIALS AND METHODS 
Lengths of guinea-pig ileum, 2 em, were prepared according to 
the previously described method (chapter 2). Using male albino rats 
(ca 200 g) T.N.O. strain Holland, pieces of duodenum were taken from 
the segment distal to the first 5 em of the duodenum from the stomach. 
A 4-min cycle time was used with the guinea-pig ileum for the addition 
of acetylcholine and bradykinin or adrenaline, the acetylcholine 
being in contact with the ileum 1 min 40 sec and the bradykinin or 
adrenaline 40 sec before washing out. With the rat duodenum a 4-min 
cycle time was used for both bradykinin and adrenaline, the substances 
being in contact with the duodenum 1 min before washing out. The a-
and a-adrenergic blockers were added r min before the addition of 
acetylcholine with the guinea-pig ileum, and with the rat duodenum 
2 min before the addition of bradykinin. A 3-min cycle time was used 
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to examine the a- and S-adrenergic blockers on the acetylcholine con-
tractions, the blockers being added 1 min before the addition of ace-
tylcholine. The acetylcholine was in contact with the ileum 1 min 
before washing out. The height of the contraction was measured at the 
termination of the 1-min contact time. 
Drugs used additional to those in chapter 2: phentolamine (Regitin 
R CIBA-Geigy, 
nolol (Inderal 
Switzerland), piperoxan (May & Baker, England), propra-
R 
, ICI, England), sotalol (MJ 1999, Mead Johnson, 
U.S.A.). 
RESULTS 
a-Adrenergic antagonists 
Phentolamine, an imidazoline derivative and piperoxan, a benzo-. 
dioxane derivative were chosen for examination as being typical com-
petitive antagonists of a-adrenergic receptors. Fig. la shows the 
effect of piperoxan on the bradykinin and adrenaline relaxation. In 
the case of bradykinin a potentiation of the relaxation can be seen 
but with adrenaline there was neither potentiation nor blockade. At 
the same time phentolamine (fig. lb) like piperoxan had no effect on 
the adrenaline relaxation, but unlike piperoxan the bradykinin relaxa-
tion was decreased. It can be observed in fig. 1 that with the adre-
naline response there was a small but significant contraction imme-
diately preceeding the maintained relaxation in the control responses. 
Both piperoxan and phentolamine blocked this small contraction, which 
recovered after washing out. Both a-adrenergic antagonists reduced 
the acetylcholine contraction height measured 1 min after addition 
of acetylcholine. The latter results suggested that there may be a 
correlation between the magnitude of the acetylcholine contraction 
and the bradykinin relaxation. 
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Fig. 1. The effect of piperoxan (fig. 1a, Pip, 4 ~g/ml) and phentolamine 
(fig. 1b, Phe 1 ~g/ml) on the bradykinin (BR, 2 ng/ml) and the 
adrenaline (Ad) 1 ~/mZJ relaxation of the acetylcholine (A) 
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20 ng/ml) contracted guinea-pig ileum. Piperoxan or phentolamine 
was added 1 min before acetylcholine) and bradykinin or adren-
aline 1 min after acetylcholine. Acetylch~Zine was in contact 
with the ileum 1 min 40 sec before washing out. 
S-Adrenergic antagonists 
The use of the two kinds of s-adrenergic blockers, propranolol 
and sotalol (MJ 1999), is justified on the grounds that sotalol has 
less marked local anaesthetic properties than propranolol (Somani et 
al., 1966). Fig. 2a shows that propranolol potentiated the bradykinin 
relaxation, while partially blocking the adrenaline relaxation. In 
fig. 2b can be seen the action of sotalol. Although the adrenaline 
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• 
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Fig. 2a 
BR 
J 
• 
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Ad 
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A 
• 
A 
• • S A 
• 
A 
Ad 
A 
Ad 
• 
A 
~~ 
1 min 
Ad 
• 
• 
~H 
1 min 
Fig. 2. The effect of propranolol (fig. 2a, Prop, 2 ~g/ml) and sotalol 
(fig. 2b, S, 20 ~g/ml) on the bradykinin (BR, 2 ng/ml) and the 
adrenaline (fig. 2a~ Ad~ 1 ~/ml; fig. 2b~ 2 ~g/ml) relaxation 
of the acetylcholine (A~ 20 ng/ml) contracted guinea-pig ileum. 
Propranolol or sotalol was added 1 min before the addition of 
acetylcholine~ and bradYkinin or adrenaline 1 min after acetyl-
choline. Acetylcholine was in contact with the ileum 1 min 40 sec 
before washing out. 
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relaxation was almost entirely blocked, the bradykinin relaxation was 
hardly affected. The adrenaline contraction was not blocked by either 
of the s-adrenergic blockers. Although the acetylcholine spike heights 
were similar after propranolol, the contraction after 1 min was mar-
kedly depressed, Only a slight effect was seen on the acetylcholine 
contraction with sotalol. A quantitive summary of the results with 
a- and S-adrenergic blockers can be found in table 1. 
Tab 1 e 1 
The effect of some a- and S-adrenergic blocking agents on the bradykinin 
and adrenaline relaxation of the acetylcholine contracted guinea-pig 
ileum. 
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o~, Bradykinin X Percentage Adrenaline " Percentage 
relaxation relaxation 
,! S.E.M. mm Blockade Potentiation ,: S.E.M. mm Blockade Potentiation 
Control* 31.0.! 2.8 (6)** 31.2.:.2.4{6} 
Piperoxan 50.0.! 4.2 {6}£> 
4 ~Jg/ml 
61.3 31.3.: 2.4 {6} 0.3 
Control 39.0 + o.a (5} 36.8.: 0.8 {5) 
Phentolamine 17.2 ~ 0.5 {5)£> 55.9 38.0.! 1.7 {5} 3.3 
I ,ug/ml 
Control 26.3.: 1.4 {7) 24.6 + 5. 9 {5) 
Propranolol 39.6.! 2.1 {7)£> 50.6 7.2 ~ 4.6 (5)£> 70.7 
2 yg/ml 
Control 33.8 :3.7 (5) 23.6:!: 3.8 (SJ 
Sotalol 34.7.: 4.0 (5) 2.7 2.0.: 1.3 (5)£> 91.5 
20 Jlg/ml 
Control 19.0.: 0.8 (4) 19.9: 2.2 (4) 
Phentolamine 23.0.: 0.9 (4).b. 21.1 5.3.:. 0.6 (4)A 73.4 
2~mi+ 
propranolol 
2 yg/ml 
Acetylcholine (20 ng/ml), except with phentolamine+ propranolol (10 ng/ml), was added 1 min 
before bradykinin or adrenaline. 
Numben of experiments in parentheses. 
Bradykinin, 2 ng/ml. 
xx Adrenaline, 1 pg/ml, el<cept with wtolol 2 yg/mJ • 
.a p..:;; 0.05 (Student's t-tett), 
a- and 6-adrenergic blockers on the acetylcholine contraction 
a- and 6-adrenergic blockers were examined for their anti-acetyl-
choline effects on the guinea-pig ileum. The results are shown in 
table 2. From these the percentage of the blockade of the acetylcholine 
Table 2 
The influence of some o- and S-adrenergic blocking agents on the acetyl-
choline contraction of the guinea-pig ileum, and calculation of the 
expected bradykinin relaxation. 
Acetylcholine contraction Bradykinin relaxation 
20 ng/ml 2 ng/ml 
Drug Control Treated % blockade %maximum Expected t:. Observed "' p• 
~ S.E.M. mm :_ S,E,M. mm contraction 
on blockade 0 
:_ S.E.M. mm :_ S.E.M. mm 
Piperoxan 33.2 + 1.5 20.5 + 1.6 38.2 ~ 2.1 
4 "g/ml 
38.9:. 1.4 (lO)h 36,1 ~ 0.8 34.8 NS 
Phentolamine 44.3+0.9 23.9 _._ 0.5 46,0:. 2.1 34,0:. 1.0 (10) 39.0 + 0.6 9.5 0,0005 
1 1-'g/ml 
Propranolol 
2 fJg/ml 
56.2:. 1,0 42,0 + 3.2 25.3.::: 1.8 47.1 ~ 1.2 (9} 31.3+0.6 32.5 
Sotolol 
20 fJg/ml 
46.1 :. 1.2 44.6:. 1,1 3.2 :. 3.7 61.0 :_2.3 (10} 23.2 :. 1.4 22.2 
0 20 ng/ml acetylcholine is token to give 63% maximum contraction for these calcularions, 
A Calculated on the basis of a linear regression between the percentage of moximum contraction wirh acetylcholine (x) 
and the relaxation of a srondord dose of bradykinin (2 ng/ml} (y} for each value, then averaged: y "'- 0,58x + 58,62 
A The observed relaxation wirh bradykinin (2 ng/ml) has been corrected assuming linearity between 1-4 ng/ml, and on 
overage control value of 21,6 :_ 1.2 (:_ S.E.M. mm,n = 11 }. Token from the prev'1ously established dose-response 
relationship (chapter 2}. See text for further detoib. 
Significant differences were determined by the x2 -test. {NS- Not significant} 
Number of experiments in parentheses. 
NS 
NS 
contraction has been calculated at the particular blocker concentration 
used. The percentage maximum contraction on blockade was then calcu-
lated using the information that a 20 ng/ml bath solution of acetyl-
choline produces a 63% maximum contraction of the ileum (chapter 2). 
For any percentage of maximum contraction there would be an expected 
relaxation with the standard dose of bradykinin (2 ng/ml). This ex-
pected bradykinin relaxation can be calculated from the regression 
equation of the percentage of maximum contraction with acetylcholine 
(x) and the relaxation (mm) of a standard dose of bradykinin (2 ng/ml) 
( y ) , where y = -0. 58x + 58.62 (chapter 2). The relaxations with brady-
kinin actually observed were taken from table 1 and corrected so as 
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to lie on the common linear dose-response relationship between 1-4 
ng/ml and giving a control response of 21.6 mrn (2 ng/ml bradykinin) 
as shown in chapter 2. The control value corresponds to that found 
in the dose-response relationship of the bradykinin relaxation after 
acetylcholine (20 ng/ml). The expected and observed relaxations were 
then statistically examined by the Chi-squared test. It can be seen 
that in the case of propranolol, piperoxan ~<d sotalol there is no 
difference between the relaxation that one would expect and that actual-
ly observed. With phentolamine the null hypothesis must be disregarded, 
there being a significant difference between the expected and observed 
results (p = 0.0005). Blockade of the bradykinin relaxation although 
observed to be 55.9 % with 1 wg/ml phentolamine is actually greater 
since phentolamine has been shown to block the acetylcholine contrac-
tion, thus giving higher theoretical control relaxations than those 
without phentolamine. This creates a greater difference between the 
theoretical control and the phentolamine treated experiments. The 
amount of blockade expected is 76.6 %. 
Combination of a- and S-adrenergic blockers 
Our experiments do not indicate participation of a-adrenergic 
receptors as mediators of the relaxation response of adrenaline on 
the guinea-pig ileum, even though it is commonly thought that both 
a- and S-adrenergic receptors contribute to the relaxation effect of 
catecholamines on intestinal smooth muscle (Jenkinson and Morton, 
1967; Lum et al., 1966). However to achieve a complete blockade of 
the adrenaline response, and possibly block any sympathomimetic action 
of bradykinin resistant to a- and 8-adrenergic blockers alone we have 
used a combination of phentolamine and propranolol. It can be seen 
in table 1 that the adrenaline relaxation was not completely blocked 
by the use of the blockers together and moreover no significantly 
greater degree of blockade was obtained than with propranolol alone. 
The bradykinin relaxation on the other hand was not diminished but 
slightly potentiated (p = 0.025). In table 1 there is an apparent 
large variation in the control responses to both bradykinin and adre-
naline. The reason for this variation is the use of different recorder 
module sensitivities; however, during a series of experiments with a 
particular drug the sensitivity was constant. 
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Action of phentolamine on the rat duodenum 
The sensitivities of the rat duodenum and the guinea-pig ileum 
were compared with regard to the effect of phentolamine on the brady-
kinin relaxation. This was undertaken since it had been previously 
reported that phentolamine was unable to decrease the relaxation of 
the rat duodenum (Antonio, 1968). In fig. 3 can be seen typical traces 
BR BR Phe BR BR BR 
1min. 
Fig. 3. The effect of phentolamine (Phe~ 10 ~g/ml) on the bradykinin 
(BR~ 1 ng/ml) relaxation of the rat duodenum. Bradykinin was in 
contact with the ileum 1 min before washing out. 
from the rat duodenum with bradykinin, and further some reduction 
after phentolamine. It should be noted that there was a decrease in 
the tonus of the duodenum after the addition of phentolamine. Dose-
response relationships were constructed for both organs with phento-
lamine (table 3). It can be seen from table 3 that the bradykinin 
relaxatio::. of the guinea-pig ileum is about 10 times more sensitive 
to the effect of phentolamine than the rat duodenum. The maximum 
measurable effect on the guinea-pig ileum by phentolamine was 67.2 % 
at 4 pg/ml, and with the rat duodenum 60.1% at 20 ~g/ml. It was not 
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Table 3 
The effect of phentolamine on the bradykinin relaxation of the acetyl-
choline contracted guinea-pig ileum and the rat duodenum with normal 
tone. 
GUINEA-PIG ILEUM 0 RAT DUODENUM 0 
Phent- Bradykinin relaxation Bradykinin 
ole mine Control T reoted %blockade Control 
pg/ml ~ S.E.M, mm + S.E.M. mm + S.E,M, mm 
0.2 28.1 ~ 4,5 27.0 ~ 4,1 3.9 (4)** 
0.4 33.8 ~ 0.7 26.2 + 0,9* 22.5 (5} 
1.0 39.0 + 0,8 17.2+0,5* 55.9 (5) 16.8 ~ 1.7 
2.0 17.6 ~ 3,5 7.5 ~ 1,9* 57.4 (5) 20.3 ~ 0.3 
4.0 17.4~4.7 5.7 ~ 1,2* 67.2 (5) 20.2.:!: 0.2 
10.0 22.0 + 1.2 
20.0 21.8 ~ 0.8 
.0. Acetylcholine, 20 ng/ml, was added 1 min before bradykinin, 2 ng/ml. 
0 Bradykinin was 1 ng/ml. 
p~0.05 {Student's t-test). 
Numbers of experiments "m parentheses. 
relaxation 
Treated 
+ S.E.M. mm 
15.5 + 1.7 
18.8 + 0.6 
16.6: 0,5* 
14.2.:!: 0.8"' 
8.7 + 0,6* 
%blockade 
7,7 (4) 
7.3 (4) 
17.8 (5) 
34.5 (5) 
60.1 (6) 
possible to use higher concentrations of phentolamine on either of 
the organs than those shown because, with the ileum, the acetylcholine 
contraction was reduced even more than 46 % and with the duodenum the 
tonus was lowered which prevented measurement of the resulting 
bradykinin relaxation. 
DISCUSSION 
The sensitivity of the acetylcholine contracted guinea-pig ileum 
to relaxation by bradykinin is of the same order (1 ng/ml) as that of 
the rat duodenum or the contraction of the rat uter:.1s. The relaxation 
of the guinea-pig ileum with adrenaline and noradrenali~e is found to 
be not so rapid in onset as that with bradykinin, a~d a small con-
traction is observed immediately preceeding the relaxation. The re-
laxation with adrenaline is maintained unlike that wit:-. bradykinin 
which returns to the elevated base-line. 
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Although piperoxan and phentolamine are a-adrenergic blockers 
they have different actions on the bradykinin relaxation. Piperoxan 
is found to potentiate and phentolamine to prevent the bradykinin 
relaxation. Both compounds were without effect on the adrenaline re-
laxation, but blocked the contraction component of the adrenaline 
response. The foregoing data thus clearly show that the effect of the 
a-adrenergic blockers is dissimilar on responses to bradykinin and 
adrenaline respectively. It would appear that the bradykinin-induced 
relaxation is not mediated through a triggering of a-adrenergic re-
ceptors. The phentolamine-induced reduction in the relaxation response 
by bradykinin is at variance with the results reported for phentolamine 
and bradykinin on the rat duodenum (Antonio, 1968). This variance may 
be explained by the different doses used. The component of contraction 
of the adrenaline response is likely mediated via a stimulation of 
a-adrenergic receptors. 
Neither of the B-adrenergic blockers prevented the bradykinin 
relaxation though propranolol was found to potentiate it. Both B-
adrenergic blockers were found to antagonize the adrenaline relaxation, 
and at the concentrations used sotalol more effectively than propra-
nolol. The contraction component of the adrenaline response is not 
blocked but slightly potentiated by the s-adrenergic blockers. The 
actions of the B-adrenergic blockers on the bradykinin and adrenaline 
responses are markedly different. It thus seems unlikely that the re-
laxation response by bradykinin is mediated by a stimulation of the 
S-adrenergic receptors. Conflicting results with B-adrenergic blockers 
on both the adrenaline and bradykinin responses have been found on 
the rat duodenum in the past (TUrker et al., 1964; Antonio, 1968). It 
appears probable that the guinea-pig ileum has a different specificity 
towards adrenaline and bradykinin than the rat duodenum. In particular 
both a- and B-adrenergic receptors may play a role in the adrenaline 
relaxation of the rat duodenum, while for the guinea-pig ileum only 
B-adrenergic receptors. The contraction component of the adrenaline 
response on the guinea-pig ileum is likely mediated though a sti-
mulation of the a-adrenergic receptors. 
With the guinea-pig ileum either of the B-adrenergic blockers 
alone are as effective as a combination of phentolamine and propranolol. 
This provides further evidence supporting the previously discussed 
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proposal that the component of a-adrenergic receptor stimulation to 
mediate relaxation plays an insignificant role in this organ, but may 
be more important in the production of contraction responses. A com-
bination of phentolamine and propranolol was found to have no effect 
on the bradykinin relaxation of the r·at duodenum (Antonio, 1968), 
while the present results on the gui~ea-pig ileum demonstrate a small 
but significant potentiation of the bradykinin relaxation, This 
potentiation is smaller than that of propranolol alone, and is sugges-
ted to be the result of arithmetic addition of the two effects, poten-
tiation by propranolol and reduction by phentolamine. 
In chapter 2 it was shown that there was no tachyphylaxis of 
the bradykinin relaxation on the guinea-pig ileum. This was presented 
as argument against the release of mediators. The present results 
support the hypothesis that catecholamines are not being released onto 
the a- or S-adrenergic receptors. There is, however, evidence that 
could be used in support of catecholamine release by bradykinin in the 
rat intestines (Montgomery, 1968). He concludes that the predominance 
of either contraction or relaxation in the rat small intestines to 
bradykinin is related to the catecholamine concentration in the various 
regions; indirect relaxation occurring in those regions containing 
the highest amounts of catecholamines. The conclusion dravm from the 
latter results is in contradiction to those of the present on the 
guinea-pig ileum and those on the rat duodenum (Antonio, 1968). 
Although no clear cut explanation can be given for these discrepances, 
it is possible that if Montgomery used high concentrations of a- and 
S-adrenergic blockers (no concentrations were given in his communica-
tion) then the tone of the organ would be so reduced as to give the 
incorrect conditions for a relaxation with any substances. Other· evi-
dence presented involving reserpine does not necessarily implicate a-
or S-adrenergic receptors. 
Piperoxan, phentolamine and propranolol have been shown to mar-
kedly reduce, while sotalol only to slightly reduce the acetylcholine 
contraction. It has been previously demonstrated (chapter 2) that there 
exists a linear inverse relationship between either the acetylcholine 
concentration or the percentage of maximum contraction and the brady-
kinin relaxation of the guinea-pig il'eum. In consequence a reduction 
in the acetylcholine contraction should result in an increase of ~he 
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bradykinin relaxation. In table 2 is shown the calculations necessary 
to measure an expected bradykinin relaxation as predicted from the 
regression equation, and further this is compared statistically using 
the Chi-squared test with the actual observed change in the bradykinin 
relaxation. Statistical analysis shows that there is no difference 
between the expected and observed bradykinin relaxations using pipe-
roxan, propranolol and sotalol. It can be concluded from these results 
that the reduction of the acetylcholine contraction is probably the 
underlying cause of the potentiation of the bradykinin relaxation. 
In the case of sotalol there is little effect on the acetylcholine 
contraction or the bradykinin relaxation. In the latter respect there 
may be correlation with the local anaesthetic properties of the diffe-
rent blockers viz. propranolol and sotalol on the muscle cell membrane. 
The phentolamine results on the other hand indicate a larger reduction 
than that actually observed. This might explain why only approximate-
ly 60 % reduction can be achieved in practice. It seems that under 
the conditions of these experiments one must consider not only the 
influence of drugs acting directly on the bradykinin relaxation, but 
also an indirect influence because of their anti-cholinergic activi-
ties. Indeed a similar situation may exist with the rat duodenum and 
generally for smooth muscle, where any changes in the tonus of the 
organ might have an influence on the measurement of the bradykinin 
relaxation. These possibilities are further discussed in chapter 4. 
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Chapter 4 
MECHANISM OF THE INHIBITORY ACTIONS OF SOME SPASMOGENS ON 
THE BRADYKININ-INDUCED RELAXATION OF THE GUINEA-PIG ILEUM 
SUMMARY 
The bradykinin relaxation of the acetylcholine contracted guinea-
pig ileum is decreased by increasing the concentration of acetyl-
choline. This finding prompted an investigation to determine whether 
other spasmogens can reduce the bradykinin relaxation; and the me-
chanisms involved. 
Linear inverse relationships were found between both the percentage 
of maximum contraction and concentrations of acetylcholine, histamine 
and eledoisin, and the bradykinin relaxation. Acetylcholine showed a 
steeper regression equation slope than histamine or eledoisin. No relat-
ionship existed for angiotensin, though low non-spasmogenic doses in the 
presence of the acetylcholine-contracted guinea-pig ileum reduced the 
bradykinin relaxation. Morphine and atropine reduced the angiotensin 
contraction and potentiated the bradykinin relaxation in its presence. 
Only atropine reduced the acetylcholine contraction and potentiated the 
bradykinin relaxation in its presence. Neither morphine nor atropine had 
any effect on the bradykinin reduction of its own responses. 
The magnitude of the bradykinin relaxation on the guinea-pig 
ileum is dependent on the manner of stimulation, rather than on the 
state of contraction, and also is sensitive to regulation by agents 
that have their actions on the parasympathetic system. Angiotensin re-
duces the bradykinin relaxation by a mechanism involving its indirect 
parasympathomimetic effects. In contrast the bradykinin reduction of 
its own relaxation is not via a parasympathetic mechanism, but is 
probably a direct action. 
INTRODUCTION 
Bradykinin is known to contract smooth muscle preparations such 
as the isolated rat uterus, the guinea-pig ileum and the rat stomach. 
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However, certain intestinal smooth muscle preparations such as those 
of the rat duodenum and the hen rectal caecum are relaxed by brady-
kinin (Rocha e Silva, 1970). In chapter 2 has been shown that brady-
kinin can relax the isolated guinea-pig ileum in the presence of con-
tractions by acetylcholine and other spasmogens, and further in chap-
ter 3, the involvement of catecholamines has been ruled out. Increa-
sing the concentration or percentage of maximum contraction of the 
guinea-pig ileum with acetylcholine decreased the bradykinin relaxa-
tion in a linear manner. The present work was designed to investigate 
whether other spasmogens can reduce the bradykinin relaxation; and, 
the mechanisms involved. 
MATERIALS AND METHODS 
The isolated guinea-pig ileum preparations were prepared accor-
ding to the method described in chapter 2. In the dose-response expe-
riments used for the calculation of the percentage of maximum con-
traction, all responses were measured without alteration of the base-
line. A 3-min cycle time was used to measure the dose-response charac-
teristics of the different spasmogens. A 4-min cycle time was used 
for the addition of the spasmogens and bradykinin, the spasmogens being 
in contact with the ileum 1 min 40 sec, and the bradykinin 40 sec before 
washing out. The sensitivity of the recording module was constant 
throughout the experiments, however the base-line was adjusted by ver-
tical displacement of the transducer where necessary, thus allowing 
the changes in the length of the ileum to be measured within the pre-
set scale and sensitivity of the recorder. The maximum contraction 
with acetylcholine can be estimated to be about 125 mm. 
In the experiments using low concentrations of angiotensin a 
4-min cycle time was used; the angiotensin was added 1 min before a 
standard dose of acetylcholine, and without washing out bradykinin was 
added 1 min thereafter. A 3-min cycle time was used with the DMPP con-
tractions, morphine being added 1 min before the DMPP. With DMPP the 
maximum contraction height attained was measured, while with angio-
tensin and acetylcholine the contracti·on height at the termination of 
1 min contact time. 
In the experiments examining the effect of morphine on the acetyl-
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choline contraction and bradykinin relaxation, a 4-min cycle time was 
used, while an 8-min cycle time was used for the angiotensin/bradykinin 
relaxation experiments. An 8-min cycle time was necessary since angio-
tensin was difficult to completely wash out and tended to be tachy-
phylactic in a 4-min cycle time. Morphine was added 1 min before the 
spasmogen. A similar protocol was used for atropine, replacing mor-
phine. 
The bradykinin reduction of its own responses required the use of 
a 5-min cycle time, bradykinin being added twice at a 1 min interval 
after acetylcholine or histamine. The second bradykinin addition was 
washed out after a 30 sec contact time. Morphine or atropine was added 
1 min before the spasmogens as required. 
Drugs used in addition to those in chapter 2; atropine sulphate 
(Merck, Germany), 1,1-dimethyl-4-phenylpiperazinium iodide(DMPP) 
(Aldrich-Europe, Belgium), morphine hydrochloride (Brocades-ACF, 
Holland). 
RESULTS 
Various spasmogens on the bradykinin relaxation 
Histamine, eledoisin and angiotensin were substituted for acetyl-
choline (see also chapter 2). Dose-response relationships for the in-
crease in the concentration and contraction produced by the spasmogens 
were constructed. The maximum contraction heights were measured at the 
termination of 1 min contact time and all lower contractions expressed 
as the percentage of the Daximum contraction of each spasmogen. The 
relaxations produced by a standard dose of bradykinin, 2 ng/ml, were 
measured after the diffe~ent concentrations of spasmogens, some of 
whic~ exceeded the concentrations required to produce the maximum 
contrac~ion. The cor~ela:io~ coefficients were calculated for each of 
the spasmogens and the subsequent bradykinin relaxations. Further, when 
correlation was found, the regression equations for the various rela-
tionships were determined, The regression lines were calculated by the 
method of least squares, from which the standard deviations of the 
regression coefficients and the standard error of the estimate (scatter) 
were calculated (Documenta Geigy). These results are summarized in 
75 
table 1. Here is shown the magnitudes of the bradykinin relaxations 
after increasing concentrations of the spasmogens, and further the re-
gression equations for the increase in the percentage of maximum con-
traction and the bradykinin relaxation. The percentages of maximum 
contraction are not shown in table 1, however, in table 2 the brady-
kinin relaxations are compared at identical percentages of maximum 
contraction (25, 50, 75, 100 %) for each spasmogen. The bradykinin 
relaxations were calculated by substitution of the fixed percentage 
of maximum contraction values into the respective regression equations. 
Table 1 
The influence of increasing doses of various contracting substances on 
the bradykinin relaxation of the isolated guinea-pig ileum. 
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Dose Bradykinin relaxation+ SEM (mm} (2 ng/ml} 
sposmogen Acetylcholine Histamine - Eledoisin Angiotensin 
ng/ml 
4 14.5 ~ 0.7 {8) 
10 43.0 2:0,7 (6}** 42.1 .::: 1.2 (6) 14.5:. 1.0 (8} 
20 21.6 2: 1.2 {11} 44.0.::: 0.4 {8) 39.6.::: 1.8 (6} 14.3 2: 1.2 (8} 
40 8.8 ~ 0.6 (5) 41.9:0.6(8} 37.0: 1.9 (4) *14. 9 2: 1.2 (8) 
100 *1.9.::: 0.2 (5} 39,9:. 0.8 (8} *34.7 ~ 0.9 (4) 15.0: 1.3 (8} 
200 1.0 2: 0.0 {5) •34.3.::: 1.2 (8} 27.2: 2.1 (4} 
Derived mathematical relaTionships between percentage of maximum contraction 
of the spasmogens end the bradykin'm relaxation 
Correlation 4 
coefficient (r) - 0.99 
- 0.93 - 0.63 no correlation 
Regre:s~on ~ 58,62 + 0.15° 48.88 + 0.11"" 59.64 + 0.66° 14,63 + 0,47 ol\.o 
coeff1c1ents - _ 
~S.D. b- 0.58 :_ 0.017°-0.13 ~ 0.012""- 0.24 :_ 0.070"" 0 
Standard error 
of estimate 2;2.41 :. 1.61 ~ 3.41 
* M.oximum contraction of sposmogen. 
Numbers of experiments in parentheses, 
6 Correlation end regression coefficients based on concentrations of sposmogen 
which do not exceed those giving maximum controcf1on; generally y ~ bx + o, 
where y "'bradykinin relaxation (mm), x "-percentage of maximum contraction. 
(Regression coefficient o with ongiot"ensin, + S.E.M.), 
• p < 0.0005 (acetylcholine), other pairs p >0~05 (t-test for regression coefficients) 
0 p < 0.0005 (histamine), other pairs p>0.05 (!-test for regression coefficients). 
It can be seen from table 1 that the bradykinin relaxation dimi-
nishes with increasing doses of acetylcholine, while for eledoisin and 
histamine even high concentrations diminish the relaxation considera-
bly less. With angiotensin there is no correlation between increasing 
concentrations or the percentage of maximum contraction and the brady-
kinin relaxation. The regression slopes for histamine and eledoisin 
were significantly different from that of acetylcholine, though only 
the regression constant for histamine was significantly different from 
that of acetylcholine, when the acetylcholine parameters are fixed. 
The regression slope for acetylcholine was significantly different from 
that of histamine, while the regression constants for acetylcholine 
and eledoisin were significantly different from that of histamine, 
when the histamine parameters are fixed. The constant for angiotensin 
was significantly different from that of acetylcholine and histamine. 
The statistical significance between the various parameters was cal-
culated using the Student's t-test for regression coefficients (Docu-
menta Geigy). In table 2 can be seen that at 25 % maximum contraction 
Table 2 
The influence of increasing the percentage of maximum contraction of 
the guinea-pig ileum by some spasmogens on the bradykinin relaxation. 
Percentage BRADYKININ (2 ng/ml) RELAXATIONS* IN THE PRESENCE OF 
of maximum 
contraction Acetylcholine Histamine Eledoisin Angiotensin 
25 44.1 45.6 53.3 14.5 
50 29.6 42.5 47.3 14.5 
75 15.1 39.0 41.3 14.5 
100 0.6 35.8 35.3 14.5 
* The relaxations ore calculated by substitution of the fixed percentage of 
maximum contraction parameter into the respective regression equations 
of table l. 
with acetylcholine and histamine, bradykinin produces very similar 
relaxations. After eledoisin the bradykinin relaxation is slightly 
higher, while after angiotensin it is very much lower. The results 
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indicate that increasing the percentage of maximum contraction with 
acetylcholine reduces the magnitude of the bradykinin relaxation 
greatest followed by eledoisin then histamine. Within the range of 
concentrations for angiotensin, as obtained when identical percentages 
of maximum contraction were considered no decrease in the bradykinin 
relaxation with increasing percentages of maximum contraction was 
observed. Not only was there a complete lack of dose-dependency between 
the angiotensin-induced contraction and the reduction of the bradykinin 
relaxation, but the relaxation was considerably smaller at 25 %maxi-
mum contraction than the other spasmogens. 
Low doses of angiotensin on the bradykinin relaxation 
To determine whether there existed a dose-response relationship 
at any concentration of angiotensin, and the bradykinin relaxation we 
examined the effect of lower concentrations of angiotensin (as compare 
to those in table 1), insufficient to produce a contraction, on the 
bradykinin relaxation of the acetylcholine contracted guinea-pig ileum. 
The results of these experiments are shown in table 3. It is observed 
Table 3 
The influence of low concentrations of angiotensin on the bradykinin 
relaxation of the acetylcholine contracted guinea-pig ileum. 
Dose of 
. . {; 
angtotensm 
ng/ml 
0.1 
0.2 
0.4 
1.0 
2.0 
4.0 
10.0 
BRADYKININ RELAXATION+ S.E.M. (mm) 
Control 0 Angiotensin treated 
20.9 + 0.5 20.6 :': 0.8 (5) .. 
24.3 + 1.4 24.3 :': 1.4 (8) 
25.3 + 0.8 22.6 :': 0,8 (8)' 
25.1 + 0.6 19.5 :': 0.5 IW 
24.5 + 0.9 16,3:': 1.4 (9)• 
28.8 + 0.6 22.3 :': 0.9 (8)• 
25,5 ~ 0.7 19.1 :': 1.1 (4)• 
Percentage reduction 
in bradykinin relaxation 
10.3 
22.0 
33.0 
22.7 
24.8 
b. Angiotensin was added 1 min before acetylcholine, 20 ng/ml, 
0 Bradykinin, 2 ng/ml. 
* p~ 0.01 (Student's t-test}. 
** Numbers of experiments in parentheses, 
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that there is a reduction of the bradykinin relaxation between 0.2 -
2.0 ng/ml angiotensin. At doses of angiotensin 2 ng/ml and higher there 
was no further reduction of the bradykinin relaxation, even though the 
guinea-pig ileum could be seen to be slightly contracted at these con-
centrations. 
Morphine on the bradykinin relaxation 
We have examined morphine, 10 ng/ml, on the contraction of the 
guinea-pig ileum by acetylcholine and angiotensin, and further on the 
bradykinin relaxation in their presence. The concentration of mor-
phine to be used) 10 ng/ml, was found to produce 77.4% blockade of 
DMPP (l~g/ml) contractions. Control responses were 32.2 ± 0.8 <± 
S.E.M., mm) and morphine treated 7.3 ± 0.9 (! S.E.M., mm, 5 experi-
ments). 
Table 4 
The effect of morphine on the angiotensin and acetylcholine contract-
ion of the guinea-pig ileum, and on the bradykinin relaxation in their 
presence. 
Spasmogen Spasmogen contraction.=. S.E.M. (mm) Bradykinin relaxation ° + S.E.M. (mm) 
Control Morphine treated !:::. Control Morphine treated 
Ang;otens;n 53.1 + 1.2 27.8 :': 1.7*(8)'* 
10 ng/ml 
20.4 + 0.7 30.6 :': l. 1'( 17) 
Acetylchol;ne 52.4 + 1.0 52.7 + 0.9 (8) 32.9 + 1.3 34.1 + 2.2 (9) 
20 ng/ml 
6. Morphine was 70 ng/ml 
o Bradykinin was 2 ng/ml 
p > 0.0005 (student's t-test) 
~-*numbers of experiments in parentheses 
In table 4 can be seen a summary of the results with morphine. 
A significant reduction of the angiotensin contraction was observed~ 
though there was no effect on the acetylcholine contraction. Further 
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can be seen a significant potentiation of the bradykinin relaxation in 
the presence of angiotensin, though there is no effect in the presence 
of acetylcholine. 
Atropine on the bradykinin relaxation 
In a manner similar to the experiments with morphine was examined 
the effect of atropine on the acetylcholine and angiotensin contraction 
and on the bradykinin relaxation in their presence. The concentration 
of atropine to be used (1 ng/ml) was found to produce 45.4% blockade 
of the DMPP (l~g/ml) contractions. Control responses were 26.0 + 1.0 
(! S.E.M., mm) and atropine treated 14.2! 1.3 (! S.E.M., rnrn, 5 expe-
riments). 
At this atropine concentration, it was found that the acetyl-
choline contraction was blocked to such a large extent that it was 
impossible to measure the bradykinin relaxation. In consequence atro-
pine was used at 0.5 ng/ml for acetylcholine, while 1 ng/ml for angio-
tensin. The results of these experiments are summarized in table 5. 
Table 5 
The effect of atropine on the angiotensin and acetylcholine contract-
ion of the guinea-pig ileum, and on the bradykinin relaxation in their 
presence. 
Spasmogen Spasmogen contraction+ S.E.M. (mm) Bradykinin relaxation° + S.E.M. (mm) 
Control Atropine treated 6 Control Atropine treated 
Angiotensin 50.2 + 1.3 
20 ng/ml 
41.0~ 1.6*(6)** 14.2 + 1.4 20.1 ~ 1.5*(6) 
Acetylcholine 55.4 + 0.6 
20 ng/m! 
35.5 :': 0.6 •(B) 21.2+0.7 34.2 :': 0.7'(7) 
D. Atropine was l.O ng/ml with angiotensin, 0.5 ng/ml with ocety1choline 
o Bradykinin was 2 ng/m! 
p ?-0.025 (student's t-test) 
**Numbers of experiments in parentheses 
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A significant reduction of the angiotensin contraction was observed, 
and also a significant potentiation of the bradykinin relaxation. 
The acetylcholine contraction is partially blocked by atropine, and at 
the same time the bradykinin relaxation is potentiated. The blockade 
of the acetylcholine contraction was greater than that of angiotensin, 
despite the fact that with angiotensin the atropine concentration was 
twice that with acetylcholine. Hith acetylcholine in the presence of 
atropine a theoretical bradykinin relaxation can be calculated from 
the acetylcholine-bradykinin regression equation of table 1. This 
relaxation was 35.3:!: 0.4 (:!: S.E.M., mrn, 8 experiments). Statistical 
examination using the Chi squared test showed no significant diffe-
rence between the theoretical relaxation and the observed relaxation 
in table 5. 
Morphine and atropine on the bradykinin reduction of its own response 
The effect of morphine, 10 ng/ml, and atropine, 1 ng/ml, has been 
examined on the bradykinin, 2 ng/ml, reduction of its own response with 
the acetylcholine, 20 ng/ml, contracted guinea-pig ileum for morphine 
(10 experiments), and the histamine, 40 ng/ml, contracted guinea-pig 
ileum for atropine (5 experiments). In fig. 1 can be seen traces sho-
BR BR BR BR 
• • • 
ACh M ACh 
Fig. 1. The lack of effect of morphine (MJ 10 ng/ml) on the bradykinin 
(BR~ 2 ng/ml) reduction of its own relaxation response on the 
acetylcholine (ACh~ 20 ng/ml) aontracted guinea-pig ileum. 
Morphine was added 1 min before ACh, and bradykinin~ added in 
-two cumulative doses at a 1 rrrin interval~ 1 min after ACh. 
81 
wing the lack of effect of morphine on the bradykinin reduction of its 
own response. It is also observed that morphine has no effect on the 
acetylcholine contraction nor on the bradykinin relaxation (see also 
table 4). In a similar manner atropine did not alter the bradykinin 
reduction of its own response on the histamine contracted guinea-pig 
ileum, nor affect the histamine contraction or the bradykinin relaxa-
tion. 
DISCUSSION 
In chapter 2 it was demonstrated that there is a linear inverse 
relationship between variation in the percentage of maximum contraction 
of the guinea-pig ileum using acetylcholine and the bradykinin relaxa-
tion in the presence of acetylcholine. It thus appeared that the magni-
tude of the bradykinin relaxation was dependent on the extent of con-
traction of the ileum by acetylcholine. It was also reported that chal-
lenge of the ileum by some other spasmogenic substances provides the 
correct conditions for the bradykinin relaxation. The present work 
shows that increasing the concentrations of spasmogens such as hista-
mine and eledoisin, does not seem to decrease the bradykinin relaxa-
tion as much as with acetylcholine. This is observed from the slopes 
of the regression equations, where acetylcholine is - 0.58, histamine 
- 0.13 and eledoisin - 0.24. In the case of angiotensin there is no 
correlation between increasing doses and the bradykinin relaxation. 
The various effects of the spasmogens on the bradykinin relaxation al-
most certainly reflects the difference in the mechanism of contraction 
of the ileum. It would appear that the fact that the state of contrac-
tion of the ileum can be changed is not sufficient criterion to expect 
a changed bradykinin relaxation. This can be further borne out, since 
when concentrations of the spasmogens were used exceeding those giving 
100 %maximum contraction i.e. with acetylcholine and eledoisin, the 
relaxations with bradykinin were further decreased. It is likely that 
further increases in the concentrations of the spasmogens would de-
crease the bradykinin relaxation even further. Even the fact that the 
ileum is in a state of contraction is not sufficient criterion to pre-
dict a bradykinin relaxation. This conclusion was derived from earlier 
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experiments (chapter 2) involving contraction of the ileum with depo-
larizing concentrations of potassium or barium chloride, none of which 
provided the conditions suitable for relaxation by bradykinin. It 
appears possible that there is at least a partial common pathway for 
the action on the bradykinin relaxation by the spasmogens, but there 
are differences in degree of stimulation and/or saturation of the 
mechanism. 
The larger reduction of the bradykinin relaxation in the presence 
of angiotensin as compared to that of histamine and eledoisin might be 
ascribed to the fact that angiotensin can exert an action on the guinea-
pig ileum via a stimulation of the parasympathetic ganglia, with the 
result of the release of acetylcholine from the post-ganglionic nerve 
endings (Khairallah and Page, 1961, 1963; Robertson and Rubin, 1962; 
Godfraind et al., 1966). On the other hand angiotensin may be reducing 
the bradykinin relaxation by a mechanism similar to that by which 
bradykinin reduces its own relaxing effect, as shown in chapter 2. 
To investigate the precise mechanisms involved the effects of 
morphine and atropine have been examined on the bradykinin relaxation 
in the presence of contraction by acetylcholine and angiotensin, and 
further in the presence of bradykinin. Morphine is known to decrease 
the amount of acetylcholine released from the pre- and postganglionic 
fibres (Paton, 1957; Pelikan, 1960). Acetylcholine contractions of 
the guinea-pig ileum were resistant to concentrations of morphine 
that antagonized DMPP-induced contractions. DMPP is a recognized 
ganglionic stimulant (Chen et al., 1951). Angiotensin contractions 
were antagonized by morphine, in agreement with Khairallah and Page 
(1961). The bradykinin relaxation in the presence of angiotensin, but 
not that in the presence of acetylcholine, was potentiated by mor-
phine. These results strongly suggest that angiotensin by its stimula-
tory action on the parasympathetic ganglia attenuates the relaxing 
properties of bradykinin on the guinea-pig ileum. It is unlikely that 
exogenous acetylcholine exerts its action on bradykinin via a mechanism 
involving ganglionic stimulation, since morphine had no effect on the 
bradykinin relaxation in the presence of acetylcholine. 
Atropine antagonized DMPP, acetylcholine and angiotensin-induced 
contractions of the guinea-pig ileum, though a somewhat lower concen-
tration of atropine was required for antagonism of the acetylcholine 
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contraction. In the presence of acetylcholine and angiote~sin the 
bradykinin relaxation could be seen to be potentiated. With acetyl~ 
choline the magnitude of the bradykinin relaxation as predicted from 
the regression equation was not significantly different from that ob-
served. The results with atropine suggested a direct involvement of 
the muscarinic acetylcholine receptors, rather than some other direct 
or indirect effect of acetylcholine. By analogy the potentiation in 
the presence of angiotensin and atropine can be ascribed to the anta-
gonistic activity of atropine on the muscarinic acetylcholine recep-
tors. It is understandable that ganglionic stimulants would be slight-
ly more resistant to the action of atropine since the acetylcholine is 
released in closer proximity to the receptors. It is difficult to 
equate that changes in spasmogenic concentrations of angiotensin pro-
duced no alteration in the bradykinin relaxation, while atropine re-
duced the angiotensin contraction and potentiated the bradykinin re-
laxation in its presence. One might speculate that the cholinergic 
component of the angiotensin action, which has its effects on the 
bradykinin relaxation, is saturated at low, non-spasmogenic concen-
trations, and this activity is separable from its indirect spasmogenic 
effect, but both activities are blocked by atropine and morphine. 
It has been suggested that for the bradykinin contraction of the 
isolated guinea-pig ileum there exists an indirect mechanism via the 
release of acetylcholine (Wiegershausen et al., 1964), though evidence 
has been presented implicating only direct mechanisms (Day and Vane, 
1963; Khairallah and Page, 1963; Gershon, 1967). The former indirect 
mechanism was the result of the finding that atropine and morphine 
reduced the contraction speed of the ileum to bradykinin, while eserine 
increased the contraction speed. Whereas the bradykinin contraction 
height of the guinea-pig ileum was unaffected by morphine or atropine 
(Walaszek et al., 1963; Wiegershausen et al., 1964), the inhibitory 
phase (probably equivalent to a relaxation on the ileum with raised 
tone) on the rabbit intestine was blocked by morphine, but not by 
atropine (Bauer et al., 1966). However, in the rat intestine the in-
hibitory effect was not blocked by either morphine or atropine (Bauer 
et al., 1966). One might conclude that for the guinea-pig ileum there 
is some form of cholinergic stimulation by bradykinin, but this does 
not contribute to the magnitude of the bradykinin contraction. It was 
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considered that the effects of atropine and morphine, and eserine on 
the contraction speed of the guinea-pig ileum may be a reflection, not 
of an action on the bradykinin contraction, but on the bradykinin re-
laxation. The rationale of this suggestion would be that the magnitude 
of the bradykinin relaxation, which occurs in the so called lag phase 
is regulated by the inherent parasympathomimetic properties of brady-
kinin. In an attempt to substantiate this hypothesis the effects of 
morphine and atropine on the bradykinin reduction of its own relaxing 
effect have been examined. Under no circumstances did atropine or 
morphine relieve the regulating influence of bradykinin on its own 
relaxation response, in contrast to the action of angiotensin on brady-
kinin; and further, morphine was not observed to affect the bradykinin 
relaxation in the presence of acetylcholine. It must be concluded that 
the bradykinin reduction of its own relaxing effect, in contrast to the 
reduction of the bradykinin relaxation by angiotensin, is not mediated 
via an action on the cholinergic innervation of the guinea-pig ileum, 
nor is the bradykinin relaxation a consequence of cholinergic stimu-
lation. These conclusions are not in contradiction to the concept of 
regulation in the magnitude of the bradykinin relaxation by cholinergic 
stimulation. 
Recently it has been suggested that potentiation of the bradykinin 
contraction by cysteine on the isolated guinea-pig ileum with normal 
tone is indirect via facilitation of acetylcholine release from nerve 
endings (Potter and Walaszek, 1972). It would be reasonable to suppose 
that other substances and manipulations producing these indirect effects 
would also potentiate the bradykinin contraction. Although exogenous 
acetylcholine was not able to potentiate the bradykinin relaxation 
(chapter 2), this does not rule out a neurogenic mechanism for the 
ileum with normal tone. Consideration of these results suggested that 
the magnitude of the components of the bradykinin response of the 
guinea-pig ileum may be regulated by the parasympathetic tone of the 
organ. If this is the case then the smaller regression slopes with 
histamine and eledoisin, as compared to acetylcholine, would be ex-
plained if a cholinergic mechanism was required to effect substantial 
changes in the bradykinin relaxation. 
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Chapter 5 
EFFECT OF PHENTOLAMINE ON THE BRADYKININ RELAXATION OF THE GUINEA-PIG 
ILEUM CONTRACTED BY VARIOUS SPASMOGENS 
SUMMARY 
The phentolamine reduction of the bradykinin relaxation on the 
isolated guinea-pig ileum was studied in the presence of various 
spasmogens. Phentolamine reduced the bradykinin relaxation most pot-
ently after acetylcholine, followed by angiotensin, then histamine 
and eledoisin. Phentolamine invariably reduced the bradykinin relax-
ation, but the amount of reduction was dependent on the initial 
spasmogen. In this respect phentolamine reduced the histamine contr-
actions greatest followed by acetylcholine and angiotensin. Eledoisin 
contractions were not affected by phentolamine. It was concluded that 
phentolamine does not have a completely aspecific spasmolytic action. 
INTRODUCTION 
It was observed in chapter 3 that piperoxan and propranolol pot-
entiated the bradykinin relaxation, while phentolamine, though not in 
the role of an a-adrenergic blocker, could be seen to reduce the rel-
axation. Potentiation of the bradykinin relaxation could be explained 
by a piperoxan or propranolol induced reduction of the initial acetyl-
choline contraction; since, a linear inverse relationship between the 
increase in the acetylcholine concentration and the relaxation prod-
uced by a constant dose of bradykinin had been previously established 
(chapter 2). The present experiments were designed to investigate 
the influence of various spasrnogens on the reduction of the bradykinin 
relaxation by phentolamine. 
MATERIALS AND METHODS 
The isolated guinea-pig ileum prepar·ations were set-up according 
to a previously described method (chapter 2). The sensitivity of the 
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recording module was constant throughout the experiments, however the 
base-line before measurement of contractions was adjusted by vertical 
displacement of the transducer where necessary, thus allowing the 
changes in the length of the ileum to be measured on the chart. The 
maximum contraction can be estimated to be 125 mm. 
A 3 min cycle time was used to measure the effect of phentolamine 
on the contraction produced by the spasmogens, phentolamine being 
added 1 min before the spasmogens. The spasmogens were in contact with 
the ileum 1 min before washing out. The contraction heights were 
measured after 1 min contact time. A 4 min cycle time was used for 
the effect of phentolamine on the bradykinin relaxation. 
RESULTS 
Phentolamine reduction of the bradykinin relaxation after various 
spasmogens 
Phentolamine, though not in the role of an a-adrenergic blocker, 
diminishes the bradykinin relaxation of the acetylcholine contracted 
guinea-pig ileum (chapter 3) and can also be shown to reduce the 
acetylcholine contraction. Since the type of contraction is involved 
in the regulation of the bradykinin relaxation (chapter 4) it was 
decided to examine the effect of phentolamine in the presence of a 
variety of spasmogens, in an attempt to discern if there were inter-
actions between the spasmogens and phentolamine. 
The bradykinin relaxations were measured in the presence of contr-
action of the ileum by convenient doses of acetylcholine, histamine, 
eledoisin and angiotensin, and in the presence of phentolamine added 
1 min before the contraction by the spasmogens. A representative ex-
periment using acetylcholine and phentolamine is shown in fig. 1. 
In the presence of contraction by acetylcholine, 20 ng/ml, it is obs-
erved that bradykinin at a concentration of 2 ng/ml produces a relax-
ation which is immediately followed by a small contraction above the 
elevated base-line. In the presence of phentolamine, 1 Wg/ml, the 
acetylcholine contraction and also the bradykinin relaxation are red-
uced. At this phentolamine concentration it was noticed that the con-
traction which followed the bradykinin relaxation was never reduced, 
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Fig. 1. The effect of phentolamine (Phe~ 1 wg/ml) on the bradykinin 
(BR~ 2 ng/ml) relaxation of the acetylcholine (A~ 20 ng/ml) 
contracted guinea-pig ileum. Phentolamine was added 1 min 
before ace-tylcholine, and bradykinin 1 rrrin after ace-tyl-
choline. Acetylcholine was in contact with the ileum 1 min 
40 sec before washing out. 
and on many occasions potentiated, as can be seen in the traces for 
fig. 1. The acetylcholine contraction, and the bradykinin relaxation 
and contraction recovered fully after washing with Tyrode soiution. 
E 
u 
~ 
With acetylcholine, histamine and angiotensin, phentolamine (1 Wg/ml) 
was used, however in the case of eledoisin 2 wg/ml was used. (The use 
of 2 Wg/ml phentolamine, which was not detected until writing, was 
fortuitous, arising out of an error in dilution. The intended dilution 
was 1 Wg/ml.) The results of the above experiments are shown in table 1. 
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Table 1 
The influence of phentolamine on the bradykinin relaxation of the 
guinea-pig ileum in the presence of contraction by various spasmogens. 
BRADYKININ RELAXATION+ S.E.M. (mmf EXPECTED RELAXATIONS (mm)* 
Sposmogens Control Phentolamine 6 Control Phentolamine 
treated treated 
Acetylcholine 39,0::0,8 17,2::0.5 (5)'* 21.6 9.5 
20 ng/ml 
Histamine J5oJ:_J,2 
40 ng/ml 
23.4 =- 0.7 (8) 41.9 27.9 
Eledoisin 
20 ng/ml 
51.9 =- 0.9 35.3 =- 0.6 {8) 39.6 26.9 
Angiotensin 
20 ng/ml 
21.4 =- 1,6 11,6 _:1: 1.0 (8) 14.3 7.8 
0 Bradykinin was 2 ng/ml. 
l> Phentolamine, added 1 min before the sposmogen, was 1 }Jg/ml, except with eledoisin 2 }Jg/ml. 
The 'EXPECTED RELAXATIONS' ore the observed relaxations corrected to lie on the regression 
eqwotions as fownd in tahle 1, chapter 4. 
** Nwmber of experiments in parentheses. 
% reduction of 
relaxation 
55.9 
33.3 
32,0 
45,5 
The bradykinin relaxations in the presence of the various spasmogens 
were then corrected so as to produce relaxations that lie on their 
respective common linear dose-response relationships, and taking the 
control responses found in table 1, chapter 4, at the specified spas-
mogen concentrations. These relaxations are termed the expected relax-
ations. The percentage of reduction of the bradykinin relaxation was 
then calculated. It can be seen that the greatest reduction by phent-
olamine is found in the presence of acetylcholine, followed by angio-
tensin, and histamine and eledoisin. 
Phentolamine effects on the contraction of the i lewn by various 
spasmogens 
In table 2 can be seen the effect of phentolamine~ 1 ~g/ml, except 
with eledoisin, 2 ~g/ml, on the acetylcholine, 20 ng/ml, histamine, 
40 ng/ml, eledoisin, 20 ng/ml and angiotensin, 20 ng/ml contractions 
of the guinea-pig ileum. With the exception of eledoisin, contraction 
of the ileum by the same concentrations previously used was found to 
be reduced by phentolamine. The histamine contraction was reduced 
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Table 2 
The influence of phentolamine on the acetylcholine, histamine, eled-
oisin and angiotensin contractions; and calculation of the theoretical 
bradykinin relaxation. 
CONTRACTION HEIGHTS (mm) BRADYKININ RELAXATION° 
Sposmogens Control Phentolomine • %reduction %maximum Theoretical A Expected* 01~ reduction 
:!:, S.E.M, :_ S.E,M, of contraction contraction (mm) (mm) of contraction 
::_ S,E.M. after phentolamine 
reduction, 6 
(theoretical) 
Acetylcf-toline 44.3::. 0,9 23.9 + 0.5 46.0_;,:2.1 (10)** 34.0 39.0 9.5 75.6 
20 ng/ml 
Histomine 46,1 .::. 1.6 14.0 + 1.0 69.8.: 1.4 (8) 18.4 46.4 27.9 39.9 
40 ng/ml 
Eledoisin 55.3.::. 0.9 53,9.::. 1.6 NS 16} 85.1 39.6 26,9 32.0 
20 ng/ml 
Angiotensin 35.8.::. 3.3 19.8.::. 2.1 44.7::_ 1.0 (6} 52.3 14.5 7.8 46,2 
20 ng/ml 
0 Bradykinin was 2 ng/ml. 
• Phentolamine 1 f-'9/ml, except with eledoisin 2 f'g/ml . 
6 The percentoges of moximum controction were for 20 ng/ml ocetylcholine 63.0%, 40 ng/ml histamine 60.9%, 20 ng/ml 
eledoisin 85.1%, 20 ng/ml ongiotensin 94,5% (see text for further details) .. 
A The 'Theoreticol brodykinin reloxotions' ore OOsed on substitution of '% moximum contraction ofter phentolamine 
reduction' results in the respective regression equotlons (see table 1 ,chapter 4) 
The 'Expected relaxations' were token from table 1. 
'* Numbers of experiments in parentheses. 
greatest. followed by angiotensin, then acetylcholine. The percentage 
of maximum contraction of each of the spasmogens in the presence of 
phentolamine was then calculated using the information that 20 ng/ml 
acetylcholine produces a 63.0% maximum contraction, 40 ng/ml histamine 
60.9%, 20 ng/ml eledoisin 85.1% and 20 ng/ml angiotensin 94.5%. These 
percentages, at the latter concentrations, comprised an integral part 
of the results needed to derive the regression equations (table 1, 
chapter 4). The theoretical bradykinin relaxations that should arise 
from these reduced contractions are then interpolated by substitution 
in the appropriate regression equation. 
On comparison of the expected reduction of the bradykinin relax-
ation by phentolamine (table 1) with the theoretical reduction (table 
2) is seen an increase from 55.9 to 75.6% with acetylcholine. With 
histamine there is a small increase, but this is probably not signif-
icant, while with eledoisin and angiotensin there is no diference 
between the expected and theoretical reductions of the bradykinin 
relaxation. 
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DISCUSSION 
With the knowledge that phentolamine reduces the bradykinin relax-
ation of the acetylcholine contracted guinea-pig ileum (chapter 3), it 
was decided to examine whether reduction of the bradykinin relaxation 
was dependent on the spasmogen by which the ileum was contracted. The 
reduction of the bradykinin relaxation with phentolamine was thus 
measured after the ileum had been contracted by a variety of spasmogens. 
To obtain uniformity and afford a comparison of the various results 
after phentolamine treatment the bradykinin relaxations were corrected 
so as to lie on their respective linear dose-response relationships 
(chapter 4). These results were termed the expected relaxations. With 
histamine, eledoisin and angiotensin it can be seen that phentolamine 
reduces the bradykinin relaxation, though the magnitude of the expected 
reduction with each are not as great as that with acetylcholine. It 
appears that the bradykinin relaxation after eledoisin and histamine, 
which is modified to a smaller extent by changes in the spasmogen 
concentrations, is less reduced by phentolamine than that after acetyl-
choline. In the case of angiotensin where increasing concentrations up 
to a maximum contraction of the ileum have no effect on the bradykinin 
relaxation (chapter 4), there is an approximately 46% reduction of the 
bradykinin relaxation with phentolamine. It can be concluded that 
contraction of the ileum alone is unlikely to be a determining factor 
for the degree of phentolamine reduction of the bradykinin relaxation. 
There appears to be some specificity between the spasmogens themselves 
and the phentolamine reduction of the bradykinin relaxation. 
The influence of phentolamine on the contraction of the ileum by 
the above spasmogens was also measured. This was conducted to find out 
if there were any particular relationships between the reduction in 
the spasmogen contraction and the bradykinin relaxation. It appeared 
that the largest reduction was with histamine (about 70%), while with 
angiotensin and acetylcholine the reduction was about 45%. The eled-
oisin contraction was not significantly reduced at the phentolamine 
concentration examined (twice that used with the other spasmogens). 
The latter results signify that phentolamine has both an anticholin-
ergic and antihistaminic action, rather than an aspecific spasmolytic 
action on the isolated guinea-pig ileum. Since there exists linear 
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inverse relationships between the percentage of maximum contraction 
and the bradykinin relaxation, and, reduction of the spasmogen contr-
action by phentolamine influences the bradykinin relaxation, a theor-
etical reduction in the bradykinin relaxation after the different 
spasmogens was calculated. The theoretical reduction of the bradykinin 
relaxation with phentolamine in the presence of acetylcholine is 
larger than that in the presence of angiotensin, histamine or eledoisin 
respectively. The increased theoretical reduction of the bradykinin 
relaxation as compared with that of the expected reduction suggests 
that acetylcholine is in some way preventing phentolamine from exert-
ing its full effect on the bradykinin relaxation. In the case of hist-
amine, eledoisin and angiotensin there seems to be no particular wide 
deviations between the theoretical and expected relaxations. 
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Chapter 6 
EFFECT OF SOME ANTI-INFLAMMATORY DRUGS ON THE 
BRADYKININ RELAXATION OF THE GUINEA-PIG ILEUM 
SUMMARY 
Indomethacin, sodium salicylate, phenylbutazone and amidopyrine 
have been examined for their effects on the bradykinin relaxation of 
the acetylcholine contracted guinea-pig ileum. At concentrations of 
the above drugs that are known to inhibit prostaglandin synthesis and 
also the bradykinin-induced bronchoconstriction of the guinea-pig 
lungs, there was generally no alteration of the bradykinin relaxation. 
In two isolated experiments the lag phase before the bradykinin contr-
action was markedly lengthened in the presence of indomethacin. At 
high concentrations of phenylbutazone the bradykinin relaxation and 
acetylcholine contraction were slightly depressed, while with high 
concentrations of amidopyrine the bradykinin relaxation was potent-
iated and acetylcholine contraction depressed. It is concluded for 
the acetylcholine contracted guinea-pig ileum that it is unlikely 
that bradykinin exerts its relaxing properties via a synthesis of 
prostaglandins or a mobilization of prostaglandin precursors, though 
it cannot be ruled out that prostaglandins are released, but do not 
cause movement of smooth muscle. 
INTRODUCTION 
Bradykinin has been implicated in forms of acute athritis, asthma, 
endotoxin shock and other inflammatory disturbances (Kellermeyer and 
Graham, 1968). The different anti-inflammatory drugs, initially found 
by empirical studies, have been examined extensively on the production, 
enzymatic destruction as well as on the direct effects of bradykinin. 
An extensive review of the subject has been written by ErdOs (1966), 
Collier (1969) and Rocha e Silva (1970). In many cases smooth muscle 
preparations were used to study the potential anti-inflammatory drugs 
and gather information on the role of bradykinin in the inflammatory 
process. These preparations have unfortunately revealed many puzzling 
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effects of bradykinin and of drugs acting against bradykinin (Collier, 
1969), such that a common denominator for the mode of action of brady-
kinin has not been found. 
Some anti-inflammatory drugs have been shown, for example, to 
antagonize the bradykinin-induced bronchoconstriction of the guinea-pig 
lungs, both in vivo and in vitro (Graeff and Moog, 1964; Collier and 
Shortley, 1963), though the drugs were found to be inactive on the 
contraction of the guinea-pig ileum by bradykinin (Collier and Shortley, 
1960; Jacques, l965a). These same anti-inflammatory drugs have been 
shown to interfere with the action of slow reacting substance in ana-
phylaxis (SRS-A)(Berry and Collier, 1964), arachidonic acid (Berry, 
1966) and slow reacting substance C (SRS-C)(Vargaftig et al., 1969), 
in guinea-pigs, rabbits and dogs. It has been demonstrated that brad-
ykinin and SRS-A can release a substance, known as rabbit aorta cont-
racting substance (RCS), from the isolated perfused sensitized guinea-
pig lungs when challenged with antigen (Piper and Vane, 1969). Other 
substances released were histamine, SRS-A, PGE 2 and PGF2a. Piper and 
Vane also observed that release of RCS by bradykinin and SRS-A could be 
antagonized by aspirin-like drugs. With the finding that arachidonic 
acid, a precursor of prostaglandins, also releases RCS from the guinea-
pig lungs, and that this release is antagonized by aspirin-like drugs 
(Vargaftig and Dao, 1971), there came the suggestion that RCS may be 
an intermediate in the synthesis of prostaglandins from arachidonic 
acid. It is now known that prostaglandin formation by homogenates of 
guinea-pig lung are antagonized by aspirin-like drugs (Vane, 1971); 
also, adrenaline-induced synthesis of prostaglandins in the isolated 
dog spleen (Ferreira et al., 1971); and, the production of prostaglan-
dins induced by thrombin in human platelets (Smith and Willis, 1971). 
Although it is unlikely that the bradykinin contraction of the 
guinea-pig ileum is mediated by the production of prostaglandins, it 
cannot be ruled out that bradykinin does not stimulate prostaglandin 
synthesis which has an, as yet, undetermined function. There is, 
however, no information available on the effects of anti-inflammatory 
drugs on the relaxation by bradykinin. It is possible that in organs 
where bradykinin elicits relaxation responses, the mechanism is indir-
ect via a stimulation of prostaglandin synthesis. If this is the case 
then one might expect the responses to be antagonized by some of the 
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anti-inflammatory drugs. The present experiments were designed to 
examine the effects of some anti-inflammatory drugs on the bradykinin 
relaxation of the acetylcholine contracted guinea-pig ileum, in an 
attempt to find antagonistic activity. 
MATERIALS AND METHODS 
Lengths of guinea-pig ileum, 2 em, were prepared according to the 
previously described method (chapter 2). A 4 min cycle time was used 
for the addition of acetylcholine and bradykinin, the acetylcholine 
being in contact with the ileum 1 min 40 sec and the bradykinin 40 sec 
before washing out. The anti-inflammatory drugs were added 1 min before 
the addition of acetylcholine. A 3 min cycle time was used to measure 
the effect of the anti-inflammatory drugs on the acetylcholine contr-
action. The anti-inflammatory drugp were added 1 min before the addit-
ion of acetylcholine, and the contraction height measured after the 
acetylcholine had been in contact with the ileum 1 min. 
Drugs used additional to those in chapter 2: indomethacin (Merck, 
Sharp and Dohme, Holland), solubilized according to Northover (1971), 
phenylbutazone (CIBA-Geigy, Switzerland), amidopyrine (Aldrich-Europe, 
Belgium), sodium salicylate (Merck, Germany). All drugs, except indo-
methacin, were dissolved in Tyrode solution and doses correspond to 
their salts. 
RESULTS 
Anti-inflammatory drugs on the bradykinin relaxation 
In table 1 can be seen a summary of the results that have been 
found with indomethacin, sodium salicylate, phenylbutazone and amido-
pyrine on both the bradykinin relaxation and acetylcholine contraction 
of the guinea-pig ileum. Indomethacin was present between 0.4 - 40 ~g/ml. 
Concentrations between 0.1- 1.0 ~g/ml fall within the range giving 
inhibition of prostaglandin synthesis in homogenates of guinea-pig lllilg 
(Vane, 1971), and 0,37 - 4.0 ~g/ml reduced the release of prostaglandins 
from the dog spleen (Ferreira et al., 1971). The sodium salicylate 
concentration (1000 ~g/ml) used is higher than that required to inhibit 
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Table 1 
The effect of some anti-inflammatory agents on the bradykinin relax-
ation and acetylcholine contraction of the guinea-pig ileum. 
Drug 
Indomethacin 
Sodium salicylate 
Phenylbutazone 
Amidopyrine 
Dose a 
1-'Q/ml 
0.4 
4.0 
8.0 
40,0 
1000.0 
4.0 
10.0 
40.0 
40.0 
100.0 
BRADYKININ RELAXATIONo 
mm + S.E.M. %Blockade of 
acetylcholine 
Control Treated contraction a 
30.0 + 0.8 29.0.!. 2.0 (4)** NS 
33,6.!. 1.6 33.8! 2,3 (4) NS 
44.3 + 2.9 40.5.:::. 2,3 (4) NS 
36.8.:::. 4.5 37.6 .:::. 4.4 (7) NS 
13,6:0.7 12.8.:::. 1.3 (6) NS 
19.8 + 0.6 18.8.:::. 0,8 (4) NS 
18.0 + 1.2 19.3.:::. 1.1 {4) NS 
17.2 + 0,3 15.9.:::. 0,5 (7)* 7.5 
24.8 + 0.3 24,5: 0.5 (4) NS 
23.8.::::0.5 25,4:0.4 (4)* 19.8 
0 Bradykinin, 2 ng/ml, was in contact with the ileum 40 sec, before washing out, 
6. The anti-inflammatory drugs were added 1 min before the acetylcholine, 
20 ng/ml. 
Significant difference between the controls and treated experiments, p.<::; 0,05 
(Student's t-test). NS- Not significant. 
Numbers of experiments in parentheses. 
prostaglandin synthesis in homogenates of guinea-pig lungs (Vane, 1971). 
Phenylbutazone was active at a concentration of 0.2 ~g/ml in reducing 
the bradykinin-induced bronchoconstriction of the isolated guinea-pig 
lungs (Greaff and Moog, 1964). In the present experiments 4.0- 40 ~g/ml 
phenylbutazone was used. Amidopyrine has been found to be effective 
against the bradykinin-induced bronchoconstriction in vivo, though is 
8 times less potent than indomethacin (Collier and Shortley, 1960, 
1963). In the present experiments concentrations between 40.0 - 100.0 
~g/ml were used. 
It is seen that indomethacin does not reduce the bradykinin relax-
ation nor is there any significant effect on the acetylcholine contr-
action. In two isolated experiments, which could not be repeated, the 
time taken for the bradykinin contraction to appear after the brady-
kinin relaxation was greatly extended. After washing the ileum the 
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effect could still be observed. Further additions of indomethacin 
increased the lag time. There was no apparent effect on the magnitude 
of the bradykinin relaxation nor on the acetylcholine contraction. 
With sodium salicylate, 1000 ~g/ml, no effect was found on either the 
bradykinin relaxation or the acetylcholine contraction. At low conc-
entrations of phenylbutazone (4 - 10 ~g/ml) there was no effect on the 
bradykinin relaxation or the acetylcholine contraction. At 40 ~g/ml 
the bradykinin relaxation and the acetylcholine contraction were 
slightly reduced. With amidopyrine there was no effect at 40 ~g/ml, 
but at 100 ~g/ml was observed a slight potentiation of the bradykinin 
relaxation and a reduction of the acetylcholine contraction. 
DISCUSSION 
Some current ideas were presented in the introduction of this 
chapter as to the probable mode of action of a few anti-inflammatory 
agents. In particular, bradykinin was considered to release prostagl-
andin precursors in the perfused sensitized guinea-pig lung preparat-
ion (Piper and Vane, 1969), and this may be extendible to other 
smooth muscle preparations. Further it was considered that indometh-
acin and salicylate derivatives had the ability to inhibit prostagl-
andin synthesis in a variety of preparations (Vane, 1971; Ferreira et 
al., 1971; Smith and Willis, 1971). This inhibition has been suggested 
as a mechanism for their therapeutic actions (Vane, 1971; Collier, 1971). 
The concentrations of anti-inflammatory drugs used 5.n the present 
experiments are within the ranges used by the former authors, and, in 
some cases higher to secure inhibition of prostaglandin synthesis. 
Under no circumstances was there a reduction of the bradykinin relax-
ation with indomethacin, nor an effect on the acetylcholine contraction. 
It is curious that in two isolated experiments it was found that the 
length of time taken for the relaxation to recover was prolonged in 
the presence of indomethacin. We were, unfortunately, unable to repeat 
these experiments even after numerous attempts. Nevertheless, a red-
uction of the magnitude of the bradykinin relaxation was not found. 
These results indicated the unlikelyhood that the bradykinin relaxation 
of the acetylcholine contracted guinea-pig ileum is mediated by a de 
novo synthesis of prostaglandins, though it cannot be ruled out that 
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bradykinin does promote prostaglandin synthesis, but the effect is not 
measureable under these experimental conditions. In the case of phen-
ylbutazone it is known that there exists a strong antagonism of SRS-A 
and the bradykinin-induced bronchoconstriction of the guinea-pig lung 
preparation, as is found with aspirin and indomethacin (Collier and 
Shortley, 1963; Berry and Collier, 1964). Of importance also, is that 
phenylbutazone can antagonize arachidonic acid contractions of the 
isolated guinea-pig ileum (Jacques, 1965a). These results point to a 
mechanism involving antagonism of prostaglandin synthesis or of arach-
idonic acid. No inhibition was found of the bradykinin relaxation at a 
low concentration, but there was a slight reduction at high concentr-
ations. This, however, may be due to a direct depressant action of 
phenylbutazone, for the acetylcholine contraction was also reduced. 
It has been previously demonstrated that there is a linear inverse 
relationship between the acetylcholine contraction and the bradykinin 
relaxation, and it is possible to predict the bradykinin relaxation 
after contractions by acetylcholine (chapters 2,3,4). In this case 
the acetylcholine contraction is slightly reduced by phenylbutazone, 
hence theoretically there should be a greater reduction of the brady-
kinin relaxation after compensation for the effect on the acetylcholine 
contraction. Nevertheless, since there is such a small degree of 
blockade, and moreover indomethacin and sodium salicylate are inactive 
it is difficult to advance a mechanism involving prostaglandin synth-
esis for the bradykinin relaxation. 
In the case of amidopyrine it is known that its anti-inflammatory 
activity can be antagonized by a-methyl DOPA and a-methyl-p-tyrosine 
(Jacques, 1965b) as well as by propranolol (Riesterer and Jacques, 
1969). These authors consider that catecholamines contribute to the 
anti-inflammatory activity of amidopyrine, and that this mechanism may 
be active in smooth muscle. It is known that the bradykinin and SRS-A 
induced bronchoconstriction of the guinea-pig lungs is antagonized by 
amidopyrine, though the potency is less than that with aspirin (Collier 
and Shortley, 1960, 1963; Berry and Collier, 1964). At the same time 
amidopyrine is known to be an antagonist of arachidonic acid induced 
contractio~s of the isolated guinea-pig ileum (Jacques, l965a). These 
results further implicate antagonism of prostaglandin synthesis or 
arachidonic acid as the basis of its therapeutic action. In the exper-
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iments presented an effect with amidopyrine was only found at high 
concentrations, and suprisingly this was a potentiation of the relax-
ation. Also observed was a reduction of the acetylcholine contraction. 
It would seem likely, on the basis of what has been previously discus-
sed concerning the acetylcholine contraction, that a decrease can 
account for the potentiation of the bradykinin relaxation. It is 
possible that released catecholamines reduce the acetylcholine contr-
action, though a more plausible explanation for amidopyrine would be 
via a direct mechanism on the smooth muscle. The prostaglandin release 
or precursor antagonism mechanisms are once again excluded. 
REFERENCES 
Berry, P.A., 1966, Slow reacting substance in anaphylaxis (SRS-A), its 
release, actions and antagonism, Ph.D. Thesis, Council of National 
Academic Awards, London. 
Berry, P.A. and H.O.J. Collier, 1964, Bronchoconstrictor action and 
antagonism of a slow-contracting substance from anaphylaxis of the 
guinea-pig isolated lung, Brit. J. Pharmacal. Chemother. 23, 201. 
Collier, H.O.J., 1969, A pharmacological analysis of aspirin, Adv. 
Pharmacal. 7, 333. 
Collier, H.O.J., 1971, Prostaglandins and aspirin, Nature (London) 232, 
17. 
Collier, H.O.J. and P.G. Shortley, 1960, Analgesic antipyretic drugs as 
antagonists of bradykinin, Brit. J. Pharmacal. Chemother. 15, 601. 
Collier, H.O.J. and P.G. Shortley, 1963, Antagonism by mefenamic and 
flufenamic acids of the bronchoconstrictor actions of kinins in the 
guinea-pig, Brit. J. Pharmacal. Chemother. 20, 345. 
ErdOs, E.G., 1966, Hypotensive peptides: Bradykinin, kallidin and 
eledoisin, Adv. Pharmacal. 4, 1. 
Ferreira, S.H., S. Moncada and J.R. Vane, 1971, Indomethacin and aspirin 
abolish prostaglandin release from the spleen, Nature New Biology 
231' 237. 
Graeff, K. and E. Moog, 1964, Vergleichende Untersuchungen tiber die 
bronchoconstrictorische und gefi:issconstrictorische Hirkung des 
Bradykinins, Histamins und Serotonins an isolierten Lungenpri:iper-
aten, Naunyn-Schmiedebergs Arch. exp. Path. u. Pharmakol. 248, 204. 
100 
Jacques, R., l965a, Suppression, by morphine and other analgesic com-
pounds, of the smooth muscle contraction produced by arachidonic 
acid peroxide~ Helv. Physiol. Acta 23, 156. 
Jacques, R., 1965b, Suppression, by a-methyl-DOPA and a-methyl-p-tyro-
sine of the anti-inflammatory action of aminopyrine, Helv. Physiol. 
Acta 23, 311. 
Ke11ermeyer, R.W. and R.C. Graham, Jr., 1968, Kinins- Possible physiol-
ogic and pathologic roles in man, New Eng. J. Med. 2?9, 29. 
Northover, B.J., 1971, Mechanism of the inhibitory action of indometha-
cin on smooth muscle, Brit. J. Pharmacal. Chemother. 41, 540. 
Piper, P.J. and J.R. Vane, 1969, Release of additional factors in ana-
phylaxis and its antagonism by anti-inflammatory drugs, Nature 
(London) 223, 29. 
Riesterer, L. and R. Jacques, 1969, Interference, by S-adrenergic 
blocking agents, with the anti-inflammatory action of various 
drugs, Helv. Physiol. Acta 26, 287. 
Rocha e Silva, M., 1970, In: Kinin Hormones, Springfield, Ill: C.C. 
Thomas Publishers. 
Smith, J.B. and A.L. Willis, 1971, Aspirin selectively inhibits prost-
aglandin production in human platelets, Nature New Biology 231, 235. 
Vane, J.R., 1971, Inhibition of prostaglandin synthesis as a mechanism 
of action for aspirin-like drugs, Nature New Biology 231, 17. 
Vargaftig, B.B. and N. Dao, 1971, Release of vasoactive susbtances from 
guinea-pig lungs by slow reacting substance C and arachidonic 
acid, Pharmacology 6, 99. 
Vargaftig, B.B., E.P. de Miranda and B. Lacoume, 1969, Inhibition by non 
steroidal anti-inflammatory agents of in vivo effects of slow 
reacting substance C, Nature (London) 222, 883. 
101 
Chapter 7 
POTENTIATION OF THE BIPHASIC BRADYKININ RESPONSE OF THE GUINEA-PIG ILEUM 
SUMMARY 
Cysteine, 2,3-dimercaptopropanol (BAL), a-thiol glycerol, and a 
synthetic pentapeptide (BPP 5a)' identical with one of the bradykinin 
potentiating peptides from the venom of Bothrops jararaca, were exam-
ined on the bradykinin relaxation and contraction of the acetylcholine 
contracted guinea-pig ileum. Each of the substances was found to pot-
entiate the bradykinin relaxation and contraction. Cysteine and BAL 
were up to ten times more potent at potentiating the bradykinin relax-
ation than the contraction. There was no potency difference for relax-
ation and contraction with a-thiol glycerol or BPPsa· High concentrat-
ions of cysteine and BAL showed inconsistent effects, at some concent-
rations potentiating and others reducing the bradykinin responses. 
Cysteine at high concentrations potentiated, while BAL reduced the 
acetylcholine contraction. The possible existence of different recept-
ors for bradykinin relaxation and contraction of the acetylcholine 
contracted guinea-pig ileum is discussed 
INTRODUCTION 
It is well documented that bradykinin can contract such organs as 
the guinea-pig ileum, the rabbit intestine, the rat uterus, stomach 
and intestines; while having a relaxant effect on the rat duodenum and 
colon (Rocha e Silva, 1970). The contractile effects of bradykinin on 
the guinea-pig ileum and the rat uterus can be shown to be potentiated 
by a variety of substances (Lewis, 1960; Picarelli et al., 1962). These 
include certain thiol compounds, such as cysteine (Lewis, 1960), 2,3-
dimercaptopropanol (BAL) and a-thiol glycerol (a-TG)(Erd6s and Wohler, 
1963; Werle et al., 1964; Ferreira and Rocha e Silva, 1962), and also 
a potentiating factor (BPF) isolated from the venom of Bothrops jarar-
aca (Ferreira, 1965). This was later shown to consist of nine differ-
ent peptides (Ferreira et al., 1970). The pentapeptide (BPP 5a) has 
been subsequently synthesized and its potentiating activity confirmed. 
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It has been proposed that the mechanism for the potentiation by thiol 
compounds is inhibition of the enzymes that destroy bradykinin, i.e. 
kininases (Lewis, 1960; Picarelli et al., 1962; Ferreira and Rocha e 
Silva, 1962; Sherman and Gautieri, 1969). There has, however, been an 
accumulation of evidence arguing against enzyme inhibition as the most 
important in vitro mechanism. Direct potentiating mechanisms have been 
proposed (Cirstea, 1965; Doleschel and Auerswald, 1966; Auerswald and 
Doleschel, 1967; Tewksbury, 1967). More recently a neurogenic mechanism 
has been suggested for the potentiation of the bradykinin contraction 
of the guinea-pig ileum by cysteine (Potter and Walaszek, 1972). They 
propose that potentiation proceeds via a facilitation of acetylcholine 
release from the nerve ending. There seems to be little work pertaining 
to the relaxation effects of bradykinin on intestinal smooth muscle, 
though one communication has examined the potentiation on the rat duo-
denum and terminal ileum by BAL, BPF and BPP 5a. (Camargo and Ferreira, 
1971). The ffnding that bradykinin can relax the acetylcholine contrac-
ted guinea-pig ileum (chapter 2) has prompted the present investigation 
into the possibility of potentiating this bradykinin response. 
MATERIALS AND METHODS 
The isolated guinea-pig ileum preparations were set-up according to 
a previously described method (chapter 2). A 4 min cycle time was used 
for the addition of acetylcholine and bradykinin, acetylcholine being 
in contact with the ileum 1 min 40 sec and bradykinin 40 sec before 
washing out. The potentiating agents were added 1 min before the addit-
ion of acetylcholine. A 3 min cycle time was used to study the effect 
of the potentiating agents on the acetylcholine contraction, the agents 
being added 1 min before the addition of acetylcholine. The acetylchol-
ine was in contact with the ileum 1 min before washing out. The height 
of the contraction was measured at the termination of the 1 min contact 
time. 
Drugs used in addition to those in chapter 2: cysteine, 2,3-dimerc-
-2 
aptopropanol (BAL), a-thiol glycerol (Merck, Germany). The 10 M cyst-
eine solution had a pH of 7.2, and thus the inhibitory effects of acid 
cysteine solutions on kininases, as found by Aarsen and Kemp (1962), 
were avoided. The synthetic pentapeptide, pyroglutamyl-lys-try-ala-pro 
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(BPP 5a)' corresponds to one of the nine peptides responsible for the 
pharmacological actions of bradykinin potentiating factor (BPF) isol-
ated from the venom of Bothrops jararaca (Ferreira et al., 1970). BPP 5a 
was synthetically prepared by Ir. E.W.B. de Leer and Mr. C. Olieman 
and I gratefully acknowledge a specimen from Prof. Dr. H.C. Beyerman, 
Department of Organic Chemistry, T.H. Delft. A sample of Sephadex G 50 
fractionated Bothrops jararaca venom, containing the low molecular 
weight peptides (BPF), was kindly donated by Dr. N. Bhargava, Depart-
ment of Pharmacology, Organon, Holland. 
RESULTS 
Cysteine and the bradykinin response 
Representative traces for the effect of cysteine on the bradykinin 
responses are shown in fig. 1. It is observed that with cysteine, 
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Fig. 1. 
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-5 -4 -2 The effect of cysteine rc5 4 2 ~ 10 ~ ~ M respectively) on the bradykinin (BR~ 2 ng/mlJ r~sf;onse of the acetylcholine (A~ 20 
ng/ml) contracted guinea-pig ileum. Cysteine was added 1 min 
before acetylcholine~ and bradykinin 1 min after acetylcholine. 
Acetylcholine was in contact with the ileum 1 min 40 sec before 
washing out. The recorder module sensitivities are the same for 
each of the horizontal groups~ however the base-lines before the 
acetylcholine contraction are different~ thus the acetylcholine 
contraction heights are not comparable in these traces. Base-
line changes Were produced by vertical displacement of the 
transducer module. 
10- 5M, only the relaxation component is potentiated there being no 
potentiation of the bradykinin contraction. At 10-4M cysteine both the 
relaxation and contraction responses were potentiated. With a high 
concentration of cysteine, 10- 2M, it can be seen that the bradykinin 
relaxation is slightly reduced, while the contraction is markedly pot-
entiated. At this concentration the acetylcholine contraction can be 
seen to be slightly potentiated. With the traces shown the recorder 
module sensi ti vi ties were the same for each experiment, though the base-
lines before acetylcholine contraction were different for each group. 
Base-line changes were produced by vertical displacement of the trans-
ducer module. It was necessary to use different base-lines since, at 
the sensitivity chosen the pen excursion would be too small for inclus-
ion of the complete bradykinin response. The effect of some cysteine 
concentrations, 10-7- 10-2M, on the bradykinin response is shown in 
table 1. Cysteine potentiated the bradykinin contraction at concentrat-
Table 1 
Effect of cysteine on the bradykinin responses of the acetylcholine 
contracted guinea-pig ileum. 
Cysteine 6 BRADYKININ CONTRACTION° 
concentration mm + S,E,M, 
BRADYKININ RELAXATION° 
mm + S.E.M, 
(M) Control Cysteine %Controls Control Cysteine 
10-7 18.3 + 1.3 1B,5 ~ 1.4 (6)** 
10-6 12.0 + 0.7 11,8 ~ 0.8 (10) NS 26.7 + 0.9 27.4 + 0.5 (11) 
10-5 11.0+0,8 11.8 ~ 0.9 (6) NS 21.9 ~ 1,3 25,8 ~ 1.6 ( 12). 
10-4 11.2+0,8 19.0 ~ 1.5 (6)' 170 25,9 ~ 1.0 32.7+ 1.2 (14)* 
10-3 13.4 + 0.5 35.5 ~ 2.1 (B)' 265 27.0+2.1 28.6 ~ 2.3 (12) 
10-2 14.1 + 1.0 27.6 ~ 1.8 {8)* 196 24.5+1.2 20.6 + 1.1 (10)* 
0 Bradykinin was 2 ng/ml. 
6. Cysteine was added 1 min before acetylcholine, 20 ng/ml. 
Significant difference between control5 and cysteine experiments, p~ 0.05 (Student's t-test}, 
NS- Not significant. 
Numbers of experiments in parentheses. 
% Controls 
NS 
NS 
liS 
122 
NS 
84 
ions between 10-4- 10-2M, and also the relaxation at 10- 5- 10-4M. There 
appeared to be no significant difference between the controls and the 
cysteine treated ilea at 10- 3M for the bradykinin relaxation. At 10-2M 
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cysteine the bradykinin relaxation was seen to be reduced. The brady-
kinin contraction seemed to show a greater maximum potentiation than 
the relaxation, though these quantities are not strictly comparable. 
2~3-dimeraaptopropanolol (BAL) and the bradykinin response 
In table 2 can be seen the effect of BAL, 10- 7- 10- 3M, on the brady-
Table 2 
Effect of BAL on the bradykinin responses of the acetylcholine contr-
acted guinea-pig ileum. 
BRADYKININ CONTRACTION° 
BAL mm + S,E.M. 
concentration 
BRADYKININ RELAXATION A 
mm + S.E.M. 
(M) Control BAL % Control Control BAL % Control 
10-7 3.2 + 0.9 4.8:': 1.1 (5) .. NS 22.4:: 1.0 21.8 :': 0.3 (5) 
10-6 4.1!. 0.3 4.5 :': 0.4 (6) NS 23.9 + 1.3 28.9 :': 1.6 (6)" 
10-5 2.0::0.7 8.7::1.1 (11)* 435 
10-4 5.2 + 1.1 17.9:: 1.3 (9)* 344 
20.5!. 0.5 24.3 :': 0.4 (11)" 
23.0 ~ 0.8 23.9 :': o.a (9) 
10-3 5.9 + 1.3 2.3 :': 0.7 (7). 39 17,3 + 0.8 16.8 :': 0.9 (7) 
0 &-adykinin was 2 ng/ml. 
b. BAL was added 1 min before acetylcholine, 20 ng/ml, 
* Significant difference between controls and BAL experiments, p~ 0,05 (Student's t-test), 
NS - Not significant, 
** Numbers of experiments in parentheses, 
NS 
121 
118 
NS 
NS 
kinin response. BAL can be observed to potentiate the contractile effects 
of bradykinin at concentrations between 10-5- 10-4M, while at a concent-
ration of 10- 3M the contraction was significantly reduced. Potentiation 
-6 -5 
of the relaxation response was observed between 10 - 10 M. No other 
significant differences were seen between the controls and the BAL 
treated ilea. The bradykinin contraction appeared to show a greater 
maximum potentiation than the relaxation, though these quantities are 
not strictly comparable. 
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a-thiol glycerol (a-TG) and the bradykinin response 
The effect of a range of concentrations of a-TG is seen in table 3. 
Tab 1 e 3 
Effect of o-thiol glycerol on the bradykinin responses of the acetyl-
choline contracted guinea-pig ileum. 
0 BRADYKININ CONTRACTION a 
n-thiol glycerol 
mm + S,E.M. 
concentration 
BRADYKININ RELAXATION 
mm ~ S.E.M. 
(M) Control "-t..G % Control Control ,~-TG % Control 
10-4 11.6+1.0 11.9 ~ 1.0 (8)** NS 22.3 ~ 2.9 21.4 ~ 3.0 (8) NS 
10-3 11.6 ~ 1.2 13.0:!:. 1.2 (9) NS 20.9 ~ 2.3 26,5 ~ 3.0 (9) NS 
5 X 10-3 10.8 + 3.6 19.2 ~ 1.8 (6)* 178 27.3 ~ 1.8 39.1 ~4.3 (7)* 144 
10-2 10.6 + 1.2 17.7~1.7(11)* 167 17.1 ~ 1.5 26.6 ~ 2.7 (12)* 143 
a Bradykinin was 2 ng/ml. 
0 ,,_TG was added 1 min before acetylcholine, 20 ng/ml, 
Significant difference between controls and n-TG experiments, p.:;;;: 0.05 (Student's t-test), 
NS - Not significant, 
** Numbers of experimenh in parentheses. 
Both the contraction and relaxation responses were potentiated at 
concentrations above 5 x 10- 3M, and further both showed similar magn-
itudes of potentiation. 
Synthetic bradykinin potentiating factor (BPP5a) and the bradykinin 
response 
In fig. 2 can be seen representative traces for the effect of BPP 5a 
-6 
on the bradykinin response. It is observed that BPPSa' 2 x 10 M, causes 
both a potentiation of the bradykinin contraction and relaxation. At 
this concentration there is no effect on the acetylcholine contraction. 
Table 4 shows the effect of increasing concentrations of BPP 5a on the 
bradykinin responses. Both the contraction 
-7 potentiated at concentrations above 10 M, 
and relaxation 
with a maximum 
responses are 
-6 
at 2 X 10 M. 
The bradykinin relaxation appeared to show a greater percentage maximum 
potentiation than the contraction, though these quantities are not 
strictly comparable. Both the bradykinin relaxation and contraction 
responses were potentiated by BPF at a threshold concentration of 2 ~g/ml. 
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Fig. 2. 
BR BR 
• 
A 
BR 
• 
A 
1 min 
The effect of BPP5 (2 x 10-
6M) on the bradykinin (BR, 2 ng/mZ! 
response of the ac~tylchoZine (A, 20 ng/ml) contracted guinea-
pig ileum. BPP5 was added 1 min before acetylcholine, and bradykinin 1 m&g after acetylcholine. Acetylcholine was in 
aontact with the ileum 1 min 40 sec befo:re washing out. 
Table 4 
Effect of BPP5 on the bradykinin responses of the acetylcholine contr-acted guinea-pfg ileum. 
" 0 BRADYKININ CONTRACTION BRADYKININ RELAXATION 
BPP Sa mm + S,E.M. mm + S.E.M, 
concentration 
(M) Control BPP Sa %Control Control BPP Sa o/o Control 
10-7 10.8 ~ 0,3 11.2 ~ 0.5 (5) ** NS 12,0 ~ 0.5 12.6 ~ 0.6 (5) NS 
2 X 10-? 11.5 + 0,6 15.3 ~ 0.9 (5)* 133 12.3 + 0,6 16.3.:;:. 0.5 (5)* 133 
4 X JO-l 9.6 + 0.7 14.6 ~ 0,9 (5)* ]52 11.2 :::.0.4 18.4 :::,o.a (Sl' 165 
2 X JQ-6 7.8 + 0.4 13,4:::.0.8 (5)* 172 9,6:::. 0,4 19,8:::.0.6 (5)* 206 
4 X JQ-6 7.6:::. 0,7 12.7:::.0,6 (5)* 167 10.8:::. o.s 22.0 ~ 0.3 (5)* 204 
--------- ----------
L>. Bradykinin was 2 ng/ml. 
0 BPP5"was added 1 min before ocety!choline, 20 ng/ml, 
Significant difference between controls ond BPP Scexperiments, p~ 0,01 (Student's t-test), NS- Not significant. 
Numbers of experiments in parentheses. 
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Various potentiating agents and the acetylcholine contraction 
Previously (chapter 2,4) it was shown that an increase in the conc-
entration of challenging acetylcholine resulted in a decrease of the 
bradykinin relaxation. With this information it has been possible to 
predict the magnitude of the bradykinin relaxation after any contraction 
by acetylcholine (chapter 3,4). It would thus seem possible to predict 
the magnitude of the bradykinin relaxation after potentiation or red-
uction of the acetylcholine contraction. In table 5 can be seen the 
Table 5 
Effect of various thiol compounds on the acetylcholine contraction of 
the guinea-pig ileum. 
"' 
Thiol compound 0 ACETYLCHOLINE CONTRACTION mm + S.E.M. 
concentration 
(M) Control Cysteine Control BAL 
10-6 46.6 + 1.5 46.4 ::: 1,7 (7) 
10-5 41.7 + 1.2 41.3:::0.9 (9) 
10-4 44.1 + 0.7 45.3:::0.2 (5)** 43.8 + 1.6 42.7 ::: 1.7 (8) 
10-3 43.8 + 0.9 47.4:::1.3 (6)* 35.8 + 2.2 27.9:::2.4 (7)* 
10-2 44.0 + 0.9 49.9:::0.9 (5)* 
6. Acetylcholine was 20 ng/ml" 
0 The thiol compound was added 1 min before acetylcholine. 
* Significant difference between controls and thiol compound experiments, 
p~ 0.05 (Student's t-test). 
** Numbers of experiments in parentheses. 
BAL on the acetylcholine contraction. It is effect of cysteine and 
observed that cysteine -3 -2 at 10 and 10 M potentiates the acetylcholine 
contraction, but there appears to be no direct effect at lower concent-
rations. A significant reduction of the acetylcholine contraction is 
seen with BAL, though only at 10- 3M, there being no effect at lower 
concentrations. These actions of cysteine and BAL on the acetylcholine 
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contraction should give rise with cysteine to a decrease in the brady-
kinin relaxation, and with BAL an increase in the bradykinin relaxation. 
a-TG and BPP5a did not affect the acetylcholine contraction at any of 
the concentrations examined. 
DISCUSSION 
It would appear that the component of relaxation by bradykinin of 
the acetylcholine contracted guinea-pig ileum is up to ten times more 
sensitive to potentiation by cysteine than the contraction. By the use 
of the various concentrations of cysteine it is possible to potentiate 
either the relaxation or contraction response without effect on the 
other. Previously (chapter 2,4,) it was seen that an increase in the 
concentration of acetylcholine resulted in a decrease in the relaxation 
by a fixed dose of bradykinin. These latter findings were quantified 
such that it was possible to predict the magnitude of the bradykinin 
relaxation after any contraction involving acetylcholine (chapter 3,4). 
A potentiation of the acetylcholine contraction by cysteine would be 
expected to result in a decreased relaxation by bradykinin, as is indeed 
observed. This indirect effect is likely to play a major role in red-
ucing the direct potentiation by cysteine, though probably there is also 
a direct depressant action of cysteine at these high concentrations. 
The bradykinin relaxation is up to ten times more sensitive to pot-
entiation by BAL than the contraction, and the threshold for potentiat-
ion of the bradykinin relaxation is seen to be ten times smaller than 
that for cysteine. It appears possible to use BAL selectively to pot-
entiate either the contraction or relaxation responses without effect 
on the other. In a manner similar to that with cysteine the effect of 
BAL on the acetylcholine contraction must be taken into consideration. 
At 10-3M BAL a reduction of the contraction is observed. This would be 
expected to lead to a potentiation of the bradykinin relaxation, but is 
not found. It is likely that at these high BAL concentrations there is 
a direct depressant action masking the potentiation effects. 
-6 The finding that BAL at 10 M potentiates only the bradykinin rel-
axation without effect on the bradykinin contraction is at variance with 
the results reported for the rat and cat intestines (Camargo and Ferreira, 
1971; Alabaster and Bakhle, 1972). In table 6 is depicted a summary of 
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Table 6 
Differences in the effects of BAL and BPP on the bradykinin response 
of various isolated intestinal preparatioMg. 
BAL BPP Sa 
bradykinin responses 
isolated organ contraction relaxation contraction relaxation 
acetylcholine contracted 
guinea-pig ileum 
rat duodenum l * 
rat terminal ileum f 
cat terminal ileum 
0 
+ 
+ potentiation, 0 no effect, - blockade 
*data from Camargo & Ferreira ( 1971). 
**data from Alabaster & Bakhle (1972). 
+ 
0 
0+ 
na 
results 
available 
+ + 
+ 0 
na 
0 results 
available 
the findings. Camargo and Ferreira demonstrated that BAL (approximately 
10-6M) had no effect on the bradykinin relaxation of the rat duodenum, 
but caused a slight potentiation on the rat terminal ileum. Further they 
found that BAL prevented the bradykinin contraction of these preparat-
ions. On the other hand it has recently been reported (Alabaster and 
Bakhle, 1972) that the bradykinin contraction of the 
terminal ileum was potentiated by BAL (approximately 
cat j ej tmum and 
-4 10 M) in some of 
their experiments. It would appear that there exists species and organ 
differences with regard to the action of BAL on the bradykinin responses 
of intestinal smooth muscle preparations. 
The results with BPPSa mirror those found with BPF on the acetyl-
choline contracted guinea-pig ileum, and the rat duodenum (Camargo and 
Ferreira, 1971). With BPP5a both the bradykinin relaxation and contr-
action responses of the guinea-pig ileum were potentiated, with a sim-
ilar threshold concentration (2 x 10- 7M). There was no effect on the 
acetylcholine contraction at the concentrations examined. These results 
are at variance, in some respects, with those of Camargo and Ferreira 
(1971), see table 6, who found that BPP 5a (approximately lo-·
5H) had no 
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effect on the bradykinin relaxation of the rat duodenum and terminal 
ileum, though potentiated the bradykinin contraction. In contrast BPP 5a 
(approximately 10-6M) was shown to have no effect on the bradykinin 
contraction of the cat jejunum (Alabaster and Bakhle, 1972). It seems 
that there are also species differences for the potentiation of brady-
kinin responses by BPF or BPPSa 
For a-thiol glycerol there is a threshold potentiation for both 
relaxation and contraction at about 5 x 10- 3M. There appears to be neither 
discrimination between potentiation of relaxation or contraction nor 
effects on the acetylcholine contraction. In these respects the action 
of BPPSa is similar. It is possible that ~TG and BPP5a act as potent-
iators of the bradykinin response of the guinea-pig ileum because of 
their inhibition of kinin breakdown, though the possibility of blockade 
of a single receptor or a non-discriminative action on multiple receptors 
cannot be excluded. 
The potentiation of the bradykinin contraction of the acetylcholine 
contracted guinea-pig ileum is unlikely to be due to a cysteine-facil-
itated release of acetylcholine from the nerve endings of the guinea-
pig ileum~ as suggested by Potter and Walaszek (1972), since increasing 
concentrations of acetylcholine had no influence on the bradykinin cont-
raction, and even reduced the bradykinin relaxation (chapter 4). Although 
exogenously applied acetylcholine was found to be ineffective at potent-
iating the bradykinin contraction, this does not rule out the possibility 
of a neurogenic mechanism on the ileum with normal tone. Nevertheless, 
these findings indicate the differences in the mechanisms of the brady-
kinin relaxation and contraction of the guinea-pig ileum that exist. 
There have been observations hinting at the existence of separate recep-
tors on the guinea-pig ileum for bradykinin (chapter 3,5). It was reported 
that the bradykinin relaxation of the acetylcholine contracted guinea-
pig ileum was reduced by phentolamine, while no reduction in the brady-
kinin contraction was observed; moreover, frequently a potentiation 
resulted. If there were one receptor common to both relaxation and cant-
action responses, one might expect both responses to be reduced by phen-
tolamine, which is not found. It cannot be completely certain that brady-
kinin receptors are involved, since phentolamine and also the potentiators 
may have ~heir specificity on a post-receptor mechanism. Although the 
results suggesting duality of the bradykinin receptors for relaxation 
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and contraction on the rat intestines (Camargo and Ferreira, 1971) could 
not be repeated for the guinea-pig ileum~ the present results do show 
discriminative effects for cysteine and BAL on the bradykinin response. 
In view of these results, it is conceivable that two discrete receptors 
for bradykinin exist on the guinea-pig ileum. These results do not rule 
out the possibility of a mechanism involving a single receptor with two 
efferent post-receptor pathways. With high concentrations of cysteine~ 
however~ the possibility cannot be eliminated that the direct effect on 
bradykinin was seconda~J, the primary effect being indirect on the 
acetylcholine contraction. With BAL this is unlikely since the observed 
effect on bradykinin is contrary to that expected on the basis of the 
influence on the acetylcholine contraction, 
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SUMMARY 
The investigations presented in this thesis are concerned with the 
conditions for and the characteristics of the bradykinin induced re-
laxation of the isolated guinea-pig ileum. 
The isolated guinea-pig ileum with normal tone when challenged by 
bradykinin produces only contraction responses. If, however, the ileum 
is first challenged by acetylcholine giving approximately 60% maximum 
contraction, bradykinin caused a relaxation immediately followed by a 
contraction. The biphasic response to bradykinin was also found when 
acetylcholine was replaced by histamine, eledoisin or prostaglandin F2a. 
A biphasic response was also produced during transmural electrical 
stimulation. The conditions for the bradykinin relaxation were not 
found in the presence of contraction of the ile11m by bradykinin itself, 
or potassium or barium chloride. Under the conditions where bradykinin 
produced a biphasic response, acetylcholine, histamine, eledoisin, 
prostaglandin F2a and lysine-vasopressin only contracted the ileum, 
while adrenaline, noradrenaline, oxytocin, calcium and magnesium chlor-
ide only relaxed the ileum. On increasing the percentage of maximum 
contraction with acetylcholine, a linear inverse relationship with the 
bradykinin-induced relaxation was found. Repeated single doses of 
bradykinin were not found to produce a tachyphylactic relaxation resp-
onse. The relaxing effect of bradykinin is more likely to be due to a 
direct effect on the muscle cell membrane than to a release of a med-
iator or to the blockade of a receptor mediating contraction. 
The possibility existed that bradykinin releases stored catecholamines 
or that bradykinin can in some way stimulate the adrenergic receptors 
with the result of relaxation of the guinea-pig ileum. The effect of 
various a- and S-adrenergic blockers have been examined on both the 
bradykinin and adrenaline relaxation of the guinea-pig ileum, as a 
means to substantiate this hypothesis. The a-adrenergic blocker piper-
oxan potentiated, while phentolamine, also an a-adrenergic blocker, 
reduced the bradykinin relaxation. Both reduced the acetylcholine 
contraction, but had no effect on the bradykinin relaxation. The 
bradykinin relaxation of the guinea-pig ileum was up to ten times more 
sensitive to phentolamine than that of the rat duodenum. The s-adren-
ergic blocker propranolol potentiated the bradykinin relaxation and 
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reduced the acetylcholine contraction. Sotalol, also a S-adrenergic 
blocker, was in these respects less potent than propranolol. The adren-
aline relaxation was partially blocked by propranolol, but almost 
completely by sotalol. A combination of phentolamine and propranolol 
slightly potentiated the bradykinin relaxation, but partially blocked 
the adrenaline relaxation. It can be concluded that the bradykinin 
relaxation is not due to a direct action on either the a- or S-adren-
ergic receptors of the guinea-pig ileum. Moreover the potentiation of 
the bradykinin relaxation by piperoxan and propranolol is probably 
indirect via a reduction of the acetylcholine contraction. The action 
of phentolamine in reducing the bradykinin relaxation cannot be ex-
plained by an effect on the acetylcholine contraction. For the isol-
ated guinea-pig ileum only S-adrenergic stimulation mediates relax-
ation with adrenaline. 
The bradykinin relaxation of the acetylcholine contracted guinea-
pig ileum is decreased by increasing the concentration of acetylchol-
ine. This finding prompted an investigation to determine whether 
other spasmogens can reduce the bradykinin relaxation, and the mech-
anisms involved. Linear inverse relationships were found between both 
the percen~ages of maximum contraction and concentrations of acetyl-
choline, histamine and eledoisin, and the bradykinin relaxation. 
Acetylcholine showed a steeper regression equation slope than eledoisin 
or histamine. No relationship existed for angiotensin, though low 
non-spasmogenic doses in the presence of acetylcholine reduced the 
bradykinin relaxation. Morphine and atropine reduced the angiotensin 
contraction, and potentiated the bradykinin relaxation in its presence. 
Only atropine reduced the acetylcholine contraction and potentiated 
the bradykinin relaxation in its presence. Neither morphine nor atropine 
had any effect on the bradykinin reduction of its own relaxation resp-
onses. The magnitude of the bradykinin relaxation of the guinea-pig 
ileum is dependent on the manner of stimulation, rather than on the 
state of contraction; and; is also sensitive to regulation by agents 
that have their actions on the parasympathetic system. Angiotensin 
reduces the bradykinin relaxation by a mechanism involving its indir-
ect parasympathomimetic effects. In contrast, the·bradykinin reduction 
of its own relaxation is not via a parasympathetic mechanism, but is 
probably a direct action. 
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It has also been considered that the magnitude of the reduction of 
the bradykinin relaxation by phentolamine may vary in the presence of 
different spasmogens. Phentolamine was shown to reduce the bradykinin 
relaxation most potently after acetylcholine, followed by angiotensin, 
then histamine and eledoisin. Phentolamine invariably reduced the 
bradykinin relaxation, but the amount of reduction was dependent on 
the initial spasmogen. In this respect phentolamine reduced the hist-
amine contraction greatest, followed by acetylcholine and angiotensin. 
The eledoisin response was not modified by phentolamine. 
The possibility that bradykinin releases prostaglandins (de novo 
synthesis) in the guinea-pig ileum, which may result in relaxation has 
been considered as a possible indirect mechanism for the bradykinin 
relaxation. Some anti-inflammatory agents known to inhibit either 
prostaglandin synthesis or block the bradykinin bronchoconstriction 
of the guinea-pig lungs have been examined for their effects on the 
bradykinin relaxation. At concentrations of indomethacin, sodium 
salicylate, phenylbutazone and amidopyrine known to inhibit prostagl-
andin synthesis there was no alteration in the bradykinin relaxation. 
In two independent experiments using indomethacin the lag period before 
the bradykinin contraction was markedly extended. At high concentrations 
of phenylbutazone the bradykinin relaxation and the acetylcholine con-
traction were slightly depressed, while high concentrations of amido-
pyrine potentiated the bradykinin relaxation and depressed the acetyl-
choline contraction. It is concluded that it is unlikely that brady-
kinin exerts its relaxing properties via a synthesis of prostagland-
ins or mobilization of prostaglandin precursors, though it cannot be 
ruled out that bradykinin does stimulate prostaglandin synthesis, but 
the resulting prostaglandins have no effect on the tone of the guinea-
pig ileum. 
Bradykinin responses have been shown to be potentiated by a number 
of substances. Accordingly the possibility of potentiation has been 
investigated on the bradykinin relaxation of the acetylcholine contract-
ed guinea-pig ileum. The substances cysteine, 2,3-dimercaptopropanol 
(BAL), a-thiolglycerol, and a synthetic pentapeptide (BPP 5a)' identical 
with one of the bradykinin potentiating peptides (BPF) isolated from 
the venom of Bothrops jararaca, have been examined on both the brady-
kinin relaxation and contraction. Each of the substances was found to 
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potentiate the bradykinin ·relaxation and contraction. Cysteine and 
BAL were up to ten times more potent at potentiating the bradykinin 
relaxation than the contraction. There was no potency difference for 
a-thiolglycerol or BPP with relaxation and contraction. High cone-Sa 
entrations of cysteine and BAL showed inconsistent effects, at some 
concentrations potentiating and others reducing the bradykinin resp-
onses. At high concentrations, cysteine potentiated, while BAL red-
uced the acetylcholine contraction. a-Thiolglycerol and BPPSa had no 
effect at any concentration examined. The possible existence of 
different receptors for the bradykinin induced relaxation and contract-
ion of the acetylcholine contracted guinea-pig ileum is discussed. 
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SAMENVATTING 
In dit proefschrift zijn onderzoekingen beschreven waarvan bet doe! 
was, de door bradykinine opgewekte relaxatie van het geisoleerde cavia 
ileum te karakteriseren en de voorwaarden waaronder deze optreedt te 
bepalen. 
Toevoeging van bradykinine aan een geisoleerd cavia ileum met nor-
male tonus veroorzaakt een contractie. In aanwezigheid van acetylcho-
line in een concentratie die 60% van de maximale contractie van het 
ileum geeft, werd na toevoeging van bradykinine een relaxatie verkre-
gen, direkt gevolgd door een contractie, Deze bifasische respons van 
bradykinine werd eveneens verkregen indien acetylcholine vervangen 
werd door histamine, eledoisine o£ prostaglandine r 2a en na transmura-
le electrische stimulatie. Geen relaxatie werd verkregen na verhoging 
van de tonus van het cavia ileum met bradykinine, kalium- of barium-
chloride. Indien, na tonus verhoging, de voorwaarden aanwezig waren 
voor een bifasische respons van bradykinine, veroorzaakten acetylcho-
line, histamine, eledoisine, prostaglandine r 2a en lysine-vasopressine 
a1een een contractie, terwijl adrenaline, noradrenaline, oxytocine, 
calcium- en magnesiumchloride a11een een relaxatie van bet ileum gaven. 
Het bleek dat de door acetylcholine veroorzaakte contractie en de ver-
volgens door bradykinine geinduceerde relaxatie negatief gecorreleerd 
waren. Na herhaalde toevoeging van bradykinine bleek de respons onver-
anderd. Het ontbreken van tachyphylaxie maakt bet waarschijnlijk dat 
de door bradykinine geinduceerde relaxatie bet resultaat is van een 
direkte werking van bradykinine op bet celmembraan van de gladde spier 
en niet bet gevolg is van een remming van een receptor die na stimula-
tie een contractie veroorzaakt. 
De mogelijkheid dat de door bradykinine veroorzaakte relaxatie van 
bet cavia ileum het gevolg is van bet vrijmaken van catecholaminen uit 
hun opslagplaats in zenuwuiteinden of bet gevolg is van een direkte 
interactie met adrenerge receptoren werd onderzocht m.b.v. enige a- en 
6-adrenerge remmers. De a-adrenerge remmer piperoxan potentieerde de 
bradykinine relaxatie terwijl phentolamine, eveneens een a-adrenerge 
remmer, een remming tot gevolg had. Beide remden echter de acetylcho-
line contractie maar hadden geen effect op de door adrenaline ~eindu­
ceerde relaxatie. De bradykinine-relaxatie van bet cavia ileum was 
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tien maal gevoeliger voor remrning door phentolamine dan bet duodenum 
van de rat. De S- adrenerge remmer propranolol, potentieerde de brady-
kinine relaxatie en remde de acetylcholine contractie. Sotalol, even-
eens een B-adrenerge rernmer, was rninder sterk werkzaam dan propranolol. 
De door adrenaline veroorzaakte relaxatie kon gedeeltelijk door pro-
pranolol worden geremd, terwijl sotalol een nagenoeg 100%-ige remming 
tot gevolg had. Met een cornbinatie van phentolamine en propranolol, 
werd een geringe potentiering van de bradykinine relaxatie en een ge-
deeltelijke remming van de adrenaline relaxatie verkregen. Hieruit 
werd geconcludeerd dat de bradykinine-relaxatie niet bet resultaat kan 
zijn van een direkte werking op a- of B- adrenerge receptoren van het 
cavia ileum. De potentiering van de bradykinine relaxatie door piper-
oxan en propranolol is waarschijnlijk het gevolg van een indirekte 
werking, te weten een remming van de acetylcholine contractie. De door 
phentolamine veroorzaakte vermindering van de bradykinine-relaxatie 
kan echter niet worden verklaard uit een werking op de acetylcholine 
contractie. De door adrenaline geinduceerde relaxatie van het cavia 
ileum vindt plaats via een stimulatie van S-adrenerge receptoren. 
De bradykinine-relaxatie, van het door acetylcholine gecontraheerde 
ileum wordt minder na verhoging van de acetylcholine concentratie in 
he~ orgaanbad. Naar aanleiding hiervan werd nagegaan of andere spasmo-
genen eveneens de bradykinine-relaxatie konden remmen~ en welk mecha-
nisme bij een dergelijke remming betrokken is. Een negatieve correla-
tie kan worden aangetoond tussen zowel het percentage van de maximale 
contractie als de concentratie acetylcholine, histamine en eledoisine 
enerzijds en de bradykinine-relaxatie anderzijds. Regressie analyse 
toonde aan dat de helling voor acetylcholine steiler was dan die voor 
eledoisine o£ histamine. Geen correlatie werd gevonden met angiotensi-
ne, hoewel lage niet spasmogene doses, na contractie door acetylcholi-
ne, de bradykinine-relaxatie remden. Morphine en atropine remden de 
angiotensine-contractie, maar potentieerden de bradykinine geinduceer-
de relaxatie indien tevens angiotensine aanwezig was. Alleen atropine 
remde de acetylcholine-contractie en potentieerde de bradykinine-re-
laxatie in aanwezigheid van acetylcholine. Morphine en atropine hadden 
beide geen effect op de door bradykin.ine geinduceerde remming van zijn 
eigen respons, De mate van de bradykinine-relaxatie op het cavia ileum 
bleek eerder afhankelijk van de wijze van stimulatie, dan van de con-
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tractie toestand zelf. Tevens bleek de bradykinine-relaxatie gevoelig 
voor stoffen die een werking hebben op het parasympathische systeem. 
Zo remde angiotensine de bradykinine-relaxatie via een mechanisme 
waarbij zijn indirekte parasympathische werking is betrokken. In te-
genstelling hiermee bleek de door bradykinine veroorzaakte remming van 
zijn eigen relaxatie niet van een parasympathische werking afhankelijk 
te zijn, maar waarschijnlijk het gevolg te zijn van een direkte wer-
king op het membraan van de gladde spier. 
Eveneens werd in overweging genomen dat de mate van vermindering 
van de bradykinine-relaxatie door phentolamine mogelijkerwijs afhanke-
lijk is van de aanwezigheid van verschillende spasmogenen. Het bleek 
dat phentolamine de bradykinine-relaxatie het sterkst remde na acetyl-
choline, vervolgens na angiotensine, dan na histamine en eledoisine. 
Phentolamine gaf altijd een remming van de bradykinine-relaxatie, maar 
de mate van de remrning was afhankelijk van de aard van het spasmogeen. 
Zo was de remming door phentolamine van de histamine-contractie het 
grootst, gevolgd door die van acetylcholine en angiotensine. De ele-
doisine respons werd niet door phentolamine beinvloed. 
De mogelijkheid dat prostaglandinen door bradykinine in het cavia 
ileum vrijgemaakt worden (de novo synthese), welke tot relaxatie zou 
kunnen leiden, wordt als een mogelijk indirekt mechanisme voor de bra-
dykinine-relaxatie beschouwd. Enige anti-inflammatoire stoffen waar-
van bekend is dat zij een remmende werking hebben op de prostaglandine 
biosynthese 6£ de bronchoconstrictoire werking van bradykinine op de 
cavia long blokkeren, zijn getoetst op hun effecten op de bradykinine-
relaxatie. Concentraties van indomethacine, natrium salicylaat, phe-
nylbutazon en amidopyrine, waarvan bekend is dat zij de biosynthese 
van prostaglandinen remmen, hadden geen invloed op de bradykinine-re-
laxatie. In tw"ee onafhankelijke experimenteD me-t indomethacine bleek 
dat de tijd die verstreek v66r dat de bradykinine-relaxatie optrad 
merkbaar werd verlengd. Met hoge concentraties van phenylbutazon wer-
den de bradykinine-relaxatie en acetylcholine-contractie in geringe 
mate geremd, terwijl hoge concentraties van amido-pyrine de bradykini-
ne-relaxatie potentieerden en de acetylcholine-contractie remden. 
Hieruit mag worden geconcludeerd dat het onwaarschijnlijk is dat de 
bradykinine-relaxatie wordt veroorzaakt door biosynthese van prosta-
glandinen of het mobiliseren van prostaglandine precursors, hoewel de 
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rnogelijkheid niet kan worden uitgesloten dat bradykinine de biosynthe-
se van prostaglandinen stimuleert, en dat gevormde prostaglandinen 
geen effect op de tonus van bet cavia ileum hebben. 
Van enkele stoffen is bekend dat zij de bradykinine respons speci-
fiek potenti€ren. Bijgevolg werd de rnogelijkheid onderzocht van een 
potenti€ring van de bradykinine-relaxatie van het door acetylcholine 
gecontraheerde ileum. Het effect van cysteine, 2,3-dimercaptopropanol 
(BAL), a-thiolglycerol en een synthetisch pentapeptide (BPP 5a)' iden-
tiek met 66n van de bradykinine potentierende peptiden (BPF) van bet 
gif van Bothrops jararaca, werd onderzocht op de door bradykinine ge-
induceerde relaxatie en contractie. Deze stoffen potentieerden zowel 
de bradykinine-relaxatie als de contractie. De bradykinine-relaxatie 
werd gepotentieerd door concentraties van cysteine en BAL die tien 
maal lager waren dan die, nodig voor potenti€ring van de bradykinine-
contractie. Geen verschil werd gevonden tussen de mate van potentiering 
van de relaxatie en contractie door a-thiolglycerol en BPPsa· Met hoge 
concentraties cysteine en BAL werden tegenstrijdige effecten gevonden; 
met bepaalde concentraties werd een potentiering en met andere een 
remming van de bradykinine effecten gevonden. Hoge concentraties cys-
teine potentieerden, maar BAL remde de acetylcholine-contractie. a-
Thiolglycerol en BPP 5a hadden geen effect op de acetylcholine-contrac-
tie. De mogelijkheid dat verschillende receptoren voor de bradykinine-
relaxatie en bradykinine-contractie, van het door acetylcholine gecon-
traheerde cavia ileum bestaan, wordt besproken. 
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